STOCK TITAN

Melar Acquisition: $2.46M deficit, going-concern warning

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Melar Acquisition Corp. I (MACI) reported a $305,323 net loss for the three months ended September 30, 2026, compared with $1,109,702 net income a year earlier. For the nine months, net income was $1,193,108 versus $4,245,933. Net cash used in operations was $386,700, compared with $537,585 in the prior-year period. MACI is a blank-check company and had not commenced operations.

On October 22, 2026, shareholders approved the proposed Everli business combination. Holders of 3,852,564 Public Shares exercised redemption rights, and approximately $0.8 million was expected to remain in the Trust Account after those redemptions. Everli's stated pre-money equity value is $180 million, subject to increase for certain financings Everli completes before closing; the transaction would make Everli MACI's wholly owned subsidiary. As of September 30, MACI had $1,525 in operating cash and a $2,464,550 working-capital deficit. Management said the deficit and expected significant costs raised substantial doubt about MACI's ability to continue as a going concern within one year after issuance of the financial statements.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 4 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Minor pointOperating cash use narrowed to $386,700 from $537,585 over the nine-month periods.

Negative

  • Major point. Forward-looking: it has not happened yet and may not happen.Substantial doubt: $2,464,550 working-capital deficit and expected significant costs.
  • Minor pointThird-quarter result: $305,323 loss versus $1,109,702 net income.
  • Minor pointNine-month net income: $1,193,108 versus $4,245,933 in 2025.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Trust balance expected: approximately $0.8 million after 3,852,564 redemptions.
Third-quarter net result $305,323 loss Three months ended September 30, 2026; compared with $1,109,702 net income in 2025.
Nine-month net income $1,193,108 Nine months ended September 30, 2026; compared with $4,245,933 in 2025.
Net cash used in operating activities $386,700 Nine months ended September 30, 2026; compared with $537,585 used in 2025.
Operating cash $1,525 As of September 30, 2026.
Working capital deficit $2,464,550 As of September 30, 2026.
Public Shares redeemed 3,852,564 Public Shares Holders exercised redemption rights following the October 22, 2026 shareholder meeting.
Trust Account balance after redemptions Approximately $0.8 million Expected to remain following the redemptions exercised after the October 22, 2026 meeting.
Everli pre-money equity value $180 million Stated value for the proposed business combination, subject to increase for certain financings Everli completes before closing.
substantial doubt financial
"deficit and expected future costs raise substantial doubt"
temporary equity financial
"presented at redemption value as temporary equity"
Equity-like securities that accounting rules require to be reported separately from permanent shareholders’ equity because the holder can force or the issuer is obligated to settle them in cash or other assets (or they will be settled on a specified date). Examples include mandatorily redeemable shares and certain convertible instruments with required cash settlement; on the balance sheet they appear between liabilities and shareholders’ equity (often called mezzanine or temporary equity) rather than as part of common equity.
Deferred Fee financial
"resulting in a Deferred Fee of $1,569,569"
original issue discount financial
"including an original issue discount of ten percent"
Original issue discount (OID) is the difference between a debt security’s face value and the lower price at which it is first sold, treated as additional interest that accrues over the life of the instrument. For investors it matters because OID raises the effective yield and changes taxable income and the holding’s cost basis over time — think of buying a $100 voucher for $90 and recognizing the $10 gain as earned interest as the voucher approaches maturity.
cashless basis technical
"holders may exercise Warrants on a cashless basis"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.
pre-money equity value financial
"pre-money equity value of Everli is $180 million"
The pre-money equity value is the total worth assigned to a company’s outstanding shares immediately before new investment is added; it represents the company’s equity “slice” before the new money changes the pie. Investors use it to calculate how much of the company they will own after a financing round and to judge whether the price per share is fair, similar to agreeing on the size of a pie before cutting it into new portions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MACI report for the third quarter of 2026?

MACI reported a $305,323 net loss for the three months ended September 30, 2026, compared with $1,109,702 net income in the same 2025 period.

How much was expected to remain in MACI's trust after the Everli vote?

Approximately $0.8 million was expected to remain in the Trust Account after holders of 3,852,564 Public Shares exercised redemption rights.

Why did MACI disclose substantial doubt about continuing as a going concern?

Management said the $2,464,550 working-capital deficit and expected significant future costs raised substantial doubt about MACI's ability to continue as a going concern within one year after the financial statements were issued. MACI had $1,525 in operating cash as of September 30, 2026.

What is Everli's stated pre-money value in the MACI transaction?

Everli's stated pre-money equity value is $180 million, subject to increase for certain financings Everli completes before closing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0002016221 false Q3 --12-31 http://fasb.org/srt/2026#ChiefFinancialOfficerMember Melar Acquisition Corp. I/Cayman 0002016221 2026-07-01 2026-09-30 0002016221 us-gaap:SubsequentEventMember 2026-10-22 2026-10-22 0002016221 2026-01-01 2026-09-30 0002016221 2025-01-01 2025-09-30 0002016221 2025-07-01 2025-09-30 0002016221 2025-12-31 0002016221 2026-09-30 0002016221 us-gaap:FairValueInputsLevel1Member 2025-12-31 0002016221 us-gaap:FairValueInputsLevel1Member 2026-09-30 0002016221 maciu:PublicWarrantsMember 2026-01-01 2026-09-30 0002016221 srt:MaximumMember maciu:PublicWarrantsMember 2026-01-01 2026-09-30 0002016221 srt:MinimumMember maciu:PublicWarrantsMember 2026-01-01 2026-09-30 0002016221 us-gaap:CommonClassAMember 2026-01-01 2026-09-30 0002016221 us-gaap:CommonClassAMember 2024-06-17 2024-06-17 0002016221 2024-06-17 2024-06-17 0002016221 maciu:InitialBusinessCombinationMember 2026-09-30 0002016221 us-gaap:CommonClassAMember maciu:InitialBusinessCombinationMember us-gaap:WarrantMember 2026-09-30 0002016221 maciu:InitialBusinessCombinationMember maciu:PrivatePlacementWarrantsMember 2025-12-31 0002016221 maciu:InitialBusinessCombinationMember maciu:PrivateWarrantsMember 2026-09-30 0002016221 maciu:InitialBusinessCombinationMember maciu:PublicWarrantsMember 2025-12-31 0002016221 maciu:InitialBusinessCombinationMember maciu:PublicWarrantsMember 2026-09-30 0002016221 maciu:InitialBusinessCombinationMember 2025-12-31 0002016221 us-gaap:CommonClassAMember 2026-09-30 0002016221 us-gaap:CommonClassBMember 2025-12-31 0002016221 us-gaap:CommonClassBMember 2026-09-30 0002016221 us-gaap:CommonClassBMember maciu:SponsorMember 2026-06-11 0002016221 us-gaap:CommonClassBMember maciu:FounderShareMember 2024-08-01 2024-08-31 0002016221 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember maciu:FounderShareMember 2024-03-11 0002016221 us-gaap:CommonClassBMember maciu:FounderShareMember 2024-03-11 0002016221 us-gaap:CommonClassBMember maciu:SponsorMember 2024-03-11 0002016221 us-gaap:CommonClassBMember maciu:SponsorMember 2024-03-11 2024-03-11 0002016221 us-gaap:CommonClassAMember 2025-12-31 0002016221 us-gaap:CommonClassAMember maciu:SponsorMember 2026-06-11 0002016221 maciu:UnderwritingAgreementMember 2025-12-31 0002016221 maciu:UnderwritingAgreementMember 2026-09-30 0002016221 us-gaap:IPOMember 2026-09-30 0002016221 maciu:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2026-09-30 0002016221 2026-06-30 0002016221 maciu:UnderwritingAgreementMember 2026-01-01 2026-09-30 0002016221 maciu:UnderwritingAgreementMember us-gaap:IPOMember 2026-09-30 0002016221 maciu:UnderwritingAgreementMember us-gaap:IPOMember 2026-01-01 2026-09-30 0002016221 maciu:UnderwritingAgreementMember 2024-06-20 0002016221 maciu:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2024-06-20 2024-06-20 0002016221 maciu:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2026-01-01 2026-09-30 0002016221 maciu:SponsorLoanMember 2025-01-01 2025-09-30 0002016221 maciu:SponsorLoanMember 2025-07-01 2025-09-30 0002016221 maciu:SponsorLoanMember 2026-01-01 2026-09-30 0002016221 maciu:SponsorLoanMember 2026-07-01 2026-09-30 0002016221 maciu:SponsorLoanMember maciu:RelatedPartyLoansMember 2025-12-31 0002016221 maciu:SponsorLoanMember maciu:RelatedPartyLoansMember 2026-09-30 0002016221 maciu:SponsorLoanMember maciu:SponsorMember 2025-01-01 2025-12-31 0002016221 maciu:SponsorLoanMember maciu:SponsorMember 2026-01-01 2026-09-30 0002016221 maciu:SponsorLoanMember maciu:SponsorMember 2026-03-30 0002016221 maciu:SponsorLoanMember maciu:SponsorMember 2025-09-29 0002016221 maciu:SponsorLoanMember maciu:SponsorMember 2025-09-12 0002016221 maciu:SponsorLoanMember 2025-08-18 0002016221 maciu:SponsorLoanMember maciu:EverliGlobalIncMember 2025-05-30 0002016221 maciu:SponsorLoanMember 2025-05-30 2025-05-30 0002016221 maciu:SponsorLoanMember 2025-05-30 0002016221 maciu:RelatedPartyLoansMember 2025-12-31 0002016221 maciu:RelatedPartyLoansMember 2026-09-30 0002016221 maciu:RelatedPartyLoansMember 2025-01-01 2025-12-31 0002016221 maciu:RelatedPartyLoansMember 2026-01-01 2026-09-30 0002016221 maciu:RelatedPartyLoansMember 2026-06-11 0002016221 maciu:RelatedPartyLoansMember maciu:WorkingCapitalLoanMember 2026-06-11 0002016221 maciu:AdministrativeServicesAgreementMember 2025-12-31 0002016221 maciu:AdministrativeServicesAgreementMember 2026-09-30 0002016221 maciu:AdministrativeServicesAgreementMember 2025-01-01 2025-09-30 0002016221 maciu:AdministrativeServicesAgreementMember 2026-01-01 2026-09-30 0002016221 maciu:AdministrativeServicesAgreementMember 2025-07-01 2025-09-30 0002016221 maciu:AdministrativeServicesAgreementMember 2026-07-01 2026-09-30 0002016221 maciu:AdministrativeServicesAgreementMember 2024-06-18 2024-06-18 0002016221 maciu:PromissoryNoteWithRelatedPartyMember maciu:SponsorMember 2024-06-20 2024-06-20 0002016221 maciu:PromissoryNoteWithRelatedPartyMember maciu:SponsorMember 2026-09-30 0002016221 us-gaap:CommonClassAMember maciu:FounderShareMember maciu:SponsorMember 2026-01-01 2026-09-30 0002016221 us-gaap:CommonClassBMember us-gaap:IPOMember maciu:FounderShareMember maciu:SponsorMember 2024-08-31 0002016221 us-gaap:CommonClassBMember us-gaap:IPOMember maciu:FounderShareMember maciu:SponsorMember 2024-03-11 0002016221 us-gaap:CommonClassBMember us-gaap:IPOMember maciu:FounderShareMember maciu:SponsorMember 2024-03-11 2024-03-11 0002016221 us-gaap:IPOMember maciu:PrivatePlacementWarrantsMember 2024-06-20 0002016221 maciu:PrivatePlacementWarrantsMember 2024-06-20 2024-06-20 0002016221 us-gaap:CommonClassAMember us-gaap:IPOMember maciu:PrivatePlacementWarrantsMember maciu:RepresentativesMember 2024-06-20 0002016221 maciu:PrivatePlacementWarrantsMember maciu:RepresentativesMember 2024-06-20 2024-06-20 0002016221 maciu:PrivatePlacementWarrantsMember maciu:SponsorMember 2024-06-20 2024-06-20 0002016221 us-gaap:IPOMember maciu:PrivatePlacementWarrantsMember maciu:SponsorMember 2024-06-20 2024-06-20 0002016221 us-gaap:IPOMember maciu:PrivatePlacementWarrantsMember maciu:SponsorMember 2024-06-20 0002016221 2024-06-20 2024-06-20 0002016221 maciu:PublicWarrantsMember maciu:InitialBusinessCombinationMember 2024-06-20 0002016221 us-gaap:CommonClassAMember us-gaap:IPOMember maciu:PublicWarrantsMember maciu:InitialBusinessCombinationMember 2024-06-20 0002016221 maciu:PublicWarrantsMember maciu:InitialBusinessCombinationMember 2024-06-20 2024-06-20 0002016221 us-gaap:CommonClassAMember maciu:InitialBusinessCombinationMember 2024-06-20 2024-06-20 0002016221 us-gaap:IPOMember maciu:InitialBusinessCombinationMember 2024-06-20 0002016221 us-gaap:OverAllotmentOptionMember maciu:InitialBusinessCombinationMember 2024-06-20 2024-06-20 0002016221 us-gaap:IPOMember maciu:InitialBusinessCombinationMember 2024-06-20 2024-06-20 0002016221 maciu:CommonClassSubjectToRedemptionMember 2026-09-30 0002016221 maciu:CommonClassSubjectToRedemptionMember 2026-07-01 2026-09-30 0002016221 maciu:CommonClassSubjectToRedemptionMember 2026-06-30 0002016221 maciu:CommonClassSubjectToRedemptionMember 2026-04-01 2026-06-30 0002016221 maciu:CommonClassSubjectToRedemptionMember 2026-03-31 0002016221 maciu:CommonClassSubjectToRedemptionMember 2026-01-01 2026-03-31 0002016221 maciu:CommonClassSubjectToRedemptionMember 2025-12-31 0002016221 maciu:NonRedeemableClassBMember 2025-01-01 2025-09-30 0002016221 maciu:RedeemableClassAOrdinarySharesMember 2025-01-01 2025-09-30 0002016221 maciu:NonRedeemableClassBMember 2025-07-01 2025-09-30 0002016221 maciu:RedeemableClassAOrdinarySharesMember 2025-07-01 2025-09-30 0002016221 maciu:NonRedeemableClassAOrdinarySharesAndClassBOrdinarySharesMember 2026-01-01 2026-09-30 0002016221 maciu:RedeemableClassAOrdinarySharesMember 2026-01-01 2026-09-30 0002016221 maciu:NonRedeemableClassAOrdinarySharesAndClassBOrdinarySharesMember 2026-07-01 2026-09-30 0002016221 maciu:RedeemableClassAOrdinarySharesMember 2026-07-01 2026-09-30 0002016221 maciu:WorkingCapitalLoanMember 2026-01-01 2026-09-30 0002016221 maciu:EverliGlobalIncMember 2025-12-31 0002016221 maciu:EverliGlobalIncMember 2026-09-30 0002016221 maciu:EverliGlobalIncMember 2025-01-01 2025-12-31 0002016221 maciu:EverliGlobalIncMember 2026-01-01 2026-09-30 0002016221 maciu:EverliGlobalIncMember 2025-10-21 0002016221 maciu:EverliGlobalIncMember 2026-03-30 0002016221 maciu:EverliGlobalIncMember 2025-09-29 0002016221 maciu:EverliGlobalIncMember 2025-09-12 0002016221 maciu:EverliGlobalIncMember 2025-08-18 0002016221 maciu:EverliGlobalIncMember 2025-05-30 0002016221 maciu:MelarAcquisitionSponsorILLCMember 2026-09-30 0002016221 us-gaap:CommonClassAMember maciu:SponsorMember maciu:MelarAcquisitionSponsorILLCMember 2026-06-11 0002016221 maciu:WorkingCapitalLoanMember maciu:MelarAcquisitionSponsorILLCMember 2026-06-11 0002016221 maciu:WorkingCapitalLoanMember maciu:MelarAcquisitionSponsorILLCMember 2026-06-11 2026-06-11 0002016221 maciu:EverliGlobalIncMember maciu:MelarAcquisitionSponsorILLCMember 2025-07-30 0002016221 maciu:MeetingRedemptionsMember maciu:MelarAcquisitionSponsorILLCMember 2026-01-01 2026-09-30 0002016221 maciu:PublicSharesMember maciu:MeetingRedemptionsMember maciu:MelarAcquisitionSponsorILLCMember 2026-09-30 0002016221 maciu:PublicSharesMember maciu:MelarAcquisitionSponsorILLCMember 2026-01-01 2026-09-30 0002016221 maciu:PublicSharesMember maciu:ShareholdersMeetingMember maciu:MelarAcquisitionSponsorILLCMember 2026-06-16 0002016221 maciu:ShareholdersMeetingMember maciu:MelarAcquisitionSponsorILLCMember 2026-06-16 2026-06-16 0002016221 maciu:ShareholdersMeetingMember maciu:MelarAcquisitionSponsorILLCMember 2026-06-16 0002016221 maciu:PublicSharesMember maciu:ShareholdersMeetingMember maciu:MelarAcquisitionSponsorILLCMember 2026-06-16 2026-06-16 0002016221 maciu:SponsorMember maciu:MelarAcquisitionSponsorILLCMember 2026-09-30 0002016221 maciu:MelarAcquisitionSponsorILLCMember 2026-01-01 2026-09-30 0002016221 us-gaap:IPOMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 0002016221 us-gaap:IPOMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 2024-06-20 0002016221 us-gaap:CommonClassAMember us-gaap:WarrantMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 0002016221 us-gaap:CommonClassAMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 2024-06-20 0002016221 maciu:SponsorMember maciu:PrivatePlacementWarrantsMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 2024-06-20 0002016221 maciu:SponsorMember maciu:PrivatePlacementWarrantsMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 0002016221 maciu:RedeemableWarrantMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 2024-06-20 0002016221 us-gaap:CommonClassAMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 0002016221 us-gaap:CommonClassAMember us-gaap:IPOMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 0002016221 us-gaap:OverAllotmentOptionMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 0002016221 us-gaap:OverAllotmentOptionMember maciu:MelarAcquisitionSponsorILLCMember 2024-06-20 2024-06-20 0002016221 2025-09-30 0002016221 2024-12-31 0002016221 us-gaap:RetainedEarningsMember 2025-09-30 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-09-30 0002016221 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0002016221 2025-06-30 0002016221 us-gaap:RetainedEarningsMember 2025-06-30 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-06-30 0002016221 2025-04-01 2025-06-30 0002016221 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0002016221 2025-03-31 0002016221 us-gaap:RetainedEarningsMember 2025-03-31 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-03-31 0002016221 2025-01-01 2025-03-31 0002016221 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0002016221 us-gaap:RetainedEarningsMember 2024-12-31 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-12-31 0002016221 us-gaap:RetainedEarningsMember 2026-09-30 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-09-30 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-09-30 0002016221 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0002016221 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0002016221 us-gaap:RetainedEarningsMember 2026-06-30 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-06-30 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-06-30 0002016221 2026-04-01 2026-06-30 0002016221 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002016221 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002016221 2026-03-31 0002016221 us-gaap:RetainedEarningsMember 2026-03-31 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-03-31 0002016221 2026-01-01 2026-03-31 0002016221 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0002016221 us-gaap:RetainedEarningsMember 2025-12-31 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-12-31 0002016221 maciu:NonRedeemableClassAOrdinarySharesAndClassBOrdinarySharesMember 2025-01-01 2025-09-30 0002016221 maciu:NonRedeemableClassAOrdinarySharesAndClassBOrdinarySharesMember 2025-07-01 2025-09-30 0002016221 us-gaap:CommonClassBMember 2026-11-16 0002016221 us-gaap:CommonClassAMember 2026-11-16 0002016221 maciu:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember 2026-01-01 2026-09-30 0002016221 maciu:ClassAOrdinarySharesParValue00001PerShareMember 2026-01-01 2026-09-30 0002016221 maciu:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember 2026-01-01 2026-09-30 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-07-01 2026-09-30 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-07-01 2026-09-30 0002016221 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-07-01 2025-09-30 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-07-01 2025-09-30 0002016221 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-09-30 0002016221 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-12-31 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-12-31 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-03-31 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-06-30 0002016221 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-01-01 2026-03-31 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-01-01 2026-03-31 0002016221 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-03-31 0002016221 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002016221 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002016221 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0002016221 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0002016221 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002016221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-04-01 2025-06-30 0002016221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-04-01 2025-06-30 0002016221 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0002016221 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0002016221 2025-01-01 2025-12-31 iso4217:USD xbrli:shares maciu:Segment iso4217:USD xbrli:shares xbrli:pure
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

  (Mark One)
  ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  

 

For the quarterly period ended September 30, 2026

 

or

 

  ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  

 

For the transition period from                    to                    

 

Commission File Number: 001-42134

 

Melar Acquisition Corp. I

(Exact name of registrant as specified in its charter)

 

Cayman Islands   87-1634103
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

143 West 72nd Street, 4th Floor
New York, New York
  10023
(Address of principal executive offices)   (Zip Code)

 

(702) 781-1120

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Units, each consisting of one Class A Ordinary Share and one-half of one redeemable Warrant   MACIU   The Nasdaq Stock Market LLC
Class A Ordinary Shares, par value $0.0001 per share   MACI   The Nasdaq Stock Market LLC
Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share   MACIW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer ☒   Smaller reporting company ☒
      Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒  No ☐

 

As of November 16, 2026, there were 9,545,544 Class A ordinary shares, par value $0.0001 per share, and 1 Class B ordinary share, par value $0.0001 per share, of the registrant issued and outstanding.

  

 

 

 

 

MELAR ACQUISITION CORP. I

 

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2026

TABLE OF CONTENTS

 

    Page
Part I. Financial Information   1
Item 1. Financial Statements   1
Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025   1
Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025   2
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2026 and 2025   3
Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025   5
Notes to Unaudited Condensed Consolidated Financial Statements   6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   21
Item 3. Quantitative and Qualitative Disclosures About Market Risk   30
Item 4. Controls and Procedures   30
Part II. Other Information   31
Item 1. Legal Proceedings   31
Item 1A. Risk Factors   31
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   31
Item 3. Defaults Upon Senior Securities   31
Item 4. Mine Safety Disclosures   31
Item 5. Other Information   31
Item 6. Exhibits   32
SIGNATURES   33

 

i

 

 

Unless otherwise stated in this Report, or the context otherwise requires, references to:

 

  ● “2025 Annual Report” are to our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC (as defined below) on March 9, 2026;
     
  ● “2026 First Quarter Form 10-Q” are to our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, as filed with the SEC on May 14, 2026;
     
  ● “Administrative Services Agreement” are to the Administrative Services Agreement, dated June 17, 2024, which we entered into with MCG (as defined below);
     
  ● “Agile Collateral Agent” are to Agile Capital Funding, LLC, a New York limited liability company, in its capacity as collateral agent;
     
  ● “Agile Intercreditor Agreement” are to the intercreditor agreement entered into by the Melar Lender with Agile Collateral Agent, Agile Lender (as defined below), YA Lender (as defined below), and which was acknowledged by Everli (as defined below), for itself and on behalf of its subsidiaries, Salvatore Palella, and Palella Holdings, LLC, a Delaware limited liability company;
     
  ● “Agile Lender” are to Agile Lending, LLC, a Virginia limited liability company;
     
  ● “Agile Parties” are to Agile Collateral Agent and Agile Lender, collectively;

 

  ● “Amended and Restated Articles” are to our Amended and Restated Memorandum and Articles of Association, as currently in effect;

 

  ● “ASC” are to the FASB (as defined below) Accounting Standards Codification;

 

  ● “ASU” are to the FASB Accounting Standards Update;

 

  ● “Board of Directors” or “Board” are to our board of directors;

 

  ● “Business Combination” are to a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities;

 

  ● “CCM” are to Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, a representative of the Underwriters (as defined below);

 

  ● “Certifying Officers” are to our Chief Executive Officer and Chief Financial Officer, together;

 

  ● “Class A Ordinary Shares” are to our Class A ordinary shares, par value $0.0001 per share;

 

  ● “Class B Ordinary Shares” are to our Class B ordinary shares, par value $0.0001 per share;

 

  ● “Closing” are to the consummation of the Everli Business Combination;

 

  ● “Combination Period” are to (i) the 30-month period, from the closing of the Initial Public Offering (as defined below) to December 20, 2026 (or such earlier date as determined by the Board), that we have to consummate an initial Business Combination, or (ii) such other period in which we must consummate an initial Business Combination pursuant to an amendment to the Amended and Restated Articles and consistent with applicable laws, regulations and stock exchange rules;

 

ii

 

 

● “Company,” “our,” “we,” or “us” are to Melar Acquisition Corp. I, a Cayman Islands exempted company;

 

● “Continental” are to Continental Stock Transfer & Trust Company, trustee of our Trust Account and warrant agent of our Warrants (as defined below);

  

  ● “Deferred Fee” are to the deferred underwriting commission to which the Underwriters are entitled that is payable only upon our completion of the initial Business Combination;

 

  ● “Escrowed Seller” are to Salvatore Palella;

 

  ● “Everli” are to Everli Global Inc., a Nevada corporation, together with its successors;

 

  ● “Everli Business Combination” are to the transactions contemplated by the Everli Merger Agreement and the related ancillary documents, collectively;

 

  ● “Everli Merger Agreement” are to the Agreement and Plan of Merger, dated July 30, 2025 and as amended on October 2, 2025 and December 8, 2025, we entered into with (i) Everli, (ii) Merger Sub (as defined below), (iii) the Sponsor (as defined below) and (iv) the Escrowed Seller, as amended by the First Everli Merger Agreement Amendment (as defined below) and the Second Everli Merger Agreement Amendment (as defined below);

 

  ● “Everli Notes” are to the First Everli Note (as defined below) and the Second Everli Note (as defined below), together;

 

  ● “Everli Registration Statement” are to the Registration Statement on Form S-4, which includes a proxy statement/prospectus, in connection with the Everli Business Combination, which was originally submitted confidentially with the SEC on January 23, 2026 and declared effective by the SEC on October 2, 2026;

 

  ● “Exchange Act” are to the Securities Exchange Act of 1934, as amended;

 

  ● “FASB” are to the Financial Accounting Standards Board;

 

  ● “First Everli Merger Agreement Amendment” are to the First Amendment to Agreement and Plan of Merger, dated October 2, 2025, we entered into with (i) Everli, (ii) Merger Sub, (iii) the Sponsor and (iv) the Escrowed Seller;

 

  ● “First Everli Note” are to the secured promissory note and pledge agreement in the principal amount of up to $3,611,111 issued to us by Everli and the Pledging Stockholder (as defined below) on May 30, 2025, as amended and restated on August 18, 2025, and further amended on September 12, 2025, September 29, 2025 and March 30, 2026;

 

  ● “Founder Shares” are to the (i) Class B Ordinary Shares initially purchased by our Sponsor prior to the Initial Public Offering and (ii) Class A Ordinary Shares that have or will be issued upon the automatic conversion of the Class B Ordinary Shares (x) at the time of our Business Combination as described in the IPO Registration Statement (as defined below) or (y) earlier at the option of the holders thereof, as described in the IPO Registration Statement; for the avoidance of doubt, such Class A Ordinary Shares will not be “Public Shares” (as defined below);

 

  ● “GAAP” are to the accounting principles generally accepted in the United States of America;

 

iii

 

 

  ● “Initial Public Offering” or “IPO” are to the initial public offering that we consummated on June 20, 2024;

 

  ● “Investment Company Act” are to the Investment Company Act of 1940, as amended;

  

  ● “IPO Promissory Note” are to that certain unsecured promissory note in the principal amount of up to $300,000 issued to our Sponsor on March 11, 2024;

 

  ● “IPO Registration Statement” are to the Registration Statement on Form S-1 initially filed with the SEC on May 31, 2024, as amended, and declared effective on June 17, 2024 (File No. 333-279899);

 

  ● “JOBS Act” are to the Jumpstart Our Business Startups Act of 2012;

 

  ● “Letter Agreement” are to the Letter Agreement, dated June 17, 2024, which we entered into with our Sponsor and our directors and officers;

 

  ● “Management” or our “Management Team” are to our executive officers;
     
  ● “MCG” are to Melar Capital Group LLC, an affiliate of the Sponsor;
     
  ● “Melar Lender” are to MCG and the Company, together;

 

  ● “Merger Sub” are to MAC I Merger Sub Inc., a Nevada corporation and our wholly owned subsidiary;

 

  ● “Nasdaq” are to The Nasdaq Stock Market LLC;

 

  ● “Nasdaq 36-Month Requirement” are to the requirement pursuant to the Nasdaq Rules (as defined below) that a SPAC (as defined below) must complete one or more Business Combinations within 36 months following the effectiveness of its initial public offering registration statement;

 

  ● “Nasdaq Rules” are to the continued listing rules of Nasdaq, as they exist as of the date of this Report;

 

  ● “Option Units” are to the 1,000,000 units that were purchased by the Underwriters pursuant to the partial exercise of the Over-Allotment Option (as defined below);

 

  ● “Ordinary Shares” are to the Class A Ordinary Shares and the Class B Ordinary Shares, together;

 

  ● “Over-Allotment Option” are to the 45-day option that the Underwriters had to purchase up to an additional 2,250,000 Option Units to cover over-allotments, if any, pursuant to the Underwriting Agreement (as defined below), which was partially exercised;

 

  ● “Pledging Stockholder” are to a certain stockholder of Everli that is a party to the First Everli Note;

  

  ● “Private Placement” are to the private placement of Private Placement Warrants (as defined below) that occurred simultaneously with the closing of our Initial Public Offering, pursuant to the Private Placement Warrants Purchase Agreements (as defined below);

 

 

iv

 

 

  ● “Private Placement Warrants” are to the warrants issued to our Sponsor, CCM and Seaport (as defined below) in the Private Placement;

 

  ● “Private Placement Warrants Purchase Agreements” are to the (i) Private Placement Warrants Purchase Agreement, dated June 17, 2024, which we entered into with our Sponsor and (ii) Private Placement Warrants Purchase Agreement, dated June 17, 2024, which we entered into with CCM and Seaport, together;

 

  ● “Public Shareholders” are to the holders of our Public Shares, including our Sponsor and Management Team to the extent our Sponsor and/or the members of our Management Team purchase Public Shares, provided that our Sponsor’s and each member of our Management Team’s status as a “Public Shareholder” will only exist with respect to such Public Shares;

 

  ● “Public Shares” are to the Class A Ordinary Shares sold as part of the Units (as defined below) in our Initial Public Offering (whether they were purchased in our Initial Public Offering or thereafter in the open market);

 

  ● “Public Warrants” are to the redeemable warrants sold as part of the Units in our Initial Public Offering (whether they were subscribed for in our Initial Public Offering or purchased in the open market);

 

  ● “Registration Rights Agreement” are to the Registration Rights Agreement, dated June 17, 2024, which we entered into with the Sponsor and the other holders party thereto;

 

  ● “Report” are to this Quarterly Report on Form 10-Q for the quarter ended September 30, 2026;

 

  ● “Seaport” are to Seaport Global Securities LLC, a representative of the Underwriters (as defined below);

 

  ● “SEC” are to the U.S. Securities and Exchange Commission;

 

  ● “Second Everli Merger Agreement Amendment” are to the Second Amendment to Agreement and Plan of Merger, dated December 8, 2025, we entered into with (i) Everli, (ii) Merger Sub, (iii) the Sponsor and (iv) the Escrowed Seller;

 

  ● “Second Everli Note” are to the secured promissory note and pledge agreement in the principal amount of up to $7,500,000 issued to MCG by Everli on October 21, 2025;

 

  ● “Securities Act” are to the Securities Act of 1933, as amended;
     
  ● “Senior Creditors” are to the Melar Lender and the YA Lender (as defined below), collectively;

 

  ● “SPAC” are to a special purpose acquisition company;

 

  ● “Sponsor” are to Melar Acquisition Sponsor I LLC, a Delaware limited liability company;

 

  ● “Sponsor Loan” are to the unsecured loan made to us by the Sponsor in connection with the Sponsor Note (as defined below);

 

v

 

 

  ● “Sponsor Note” are to the unsecured promissory note in the principal amount of up to $3,611,111 issued by us to the Sponsor on May 30, 2025, as amended and restated on August 18, 2025, and further amended on September 12, 2025, September 29, 2025 and March 30, 2026;

 

  ● “Trust Account” are to the U.S.-based trust account in which an amount of $160,000,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants in the Private Placement was placed following the closing of the Initial Public Offering;

 

  ● “Trust Agreement” are to the Investment Management Trust Agreement, dated June 17, 2024, which we entered into with Continental, as trustee of the Trust Account;

 

  ● “Underwriters” are to the several underwriters of the Initial Public Offering, collectively;

 

  ● “Underwriting Agreement” are to the Underwriting Agreement, dated June 17, 2024, which we entered into with CCM and Seaport, as representatives of the Underwriters;

 

  ● “Units” are to the units sold in our Initial Public Offering, which consist of one Public Share and one-half of one Public Warrant;

 

  ● “Warrant Agreement” are to the Warrant Agreement, dated June 17, 2024, which we entered into with Continental, as Warrant agent;

 

  ● “Warrants” are to the Private Placement Warrants and the Public Warrants, together;

 

  ● “Working Capital Loans” are to funds that, in order to provide working capital or finance transaction costs in connection with a Business Combination, the Sponsor, or an affiliate of the Sponsor, or certain of our directors and officers may, but are not obligated to, loan us;
     
  ● “YA Lender” are to YA II PN, Ltd., a Cayman Islands exempt limited company; and
     
  ● “Yorkville Intercreditor Agreement” are to the intercreditor agreement entered into by Melar Lender with the YA Lender, Everli, for itself and on behalf of its subsidiaries, Salvatore Palella, and Palella Holdings LLC, a Delaware limited liability company.

 

vi

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

MELAR ACQUISITION CORP. I

CONDENSED CONSOLIDATED BALANCE SHEETS

 

    September 30,        
    2026     December 31,  
    (Unaudited)     2025  
ASSETS            
Current assets            
Cash   $ 1,525     $ 32,075  
Due from Everli     4,279,773       3,805,862  
Prepaid expenses     4,857       70,852  
Total current assets     4,286,155       3,908,789  
                 
Marketable securities and cash held in Trust Account     43,502,200       171,405,977  
TOTAL ASSETS   $ 47,788,355     $ 175,314,766  
                 
LIABILITIES AND SHAREHOLDERS’ DEFICIT                
Current liabilities                
Accounts payable and accrued liabilities   $ 2,179,241     $ 576,961  
Working Capital Loan - related party     302,784       —  
Sponsor Loan     4,268,680       3,718,011  
Total current liabilities     6,750,705       4,294,972  
Deferred Fee     1,569,569       6,600,000  
TOTAL LIABILITIES     8,320,274       10,894,972  
                 
COMMITMENTS AND CONTINGENCIES (Note 6)                
                 
Class A Ordinary Shares subject to possible redemption, 3,923,923 and 16,000,000 shares at redemption value of $11.09 and $10.71 per share at September 30, 2026 and December 31, 2025, respectively     43,502,200       171,405,977  
                 
SHAREHOLDERS’ DEFICIT                
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding at September 30, 2026 and December 31, 2025     —       —  
Class A Ordinary Shares, $0.0001 par value; 500,000,000 shares authorized; 5,621,621 and 0 shares issued and outstanding (excluding 3,923,923 and 16,000,000 shares subject to possible redemption) at September 30, 2026 and December 31, 2025, respectively     562       —  
Class B Ordinary Shares, $0.0001 par value; 50,000,000 shares authorized; 1 and 5,621,622 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively     —       562  
Additional paid-in capital     —       —  
Accumulated deficit     (4,034,681 )     (6,986,745 )
TOTAL SHAREHOLDERS’ DEFICIT     (4,034,119 )     (6,986,183 )
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT   $ 47,788,355     $ 175,314,766  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1

 

 

MELAR ACQUISITION CORP. I

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
General and administrative costs   $ 687,058     $ 712,021     $ 2,054,980     $ 1,102,257  
Loss from operations     (687,058 )     (712,021 )     (2,054,980 )     (1,102,257 )
                                 
Other income (expense):                                
Interest income due from Everli     159,707       392,370       473,911       394,910  
Interest expense on Working Capital Loan     (10,797 )     —       (18,555 )     —  
Interest expense on Sponsor Loan     (159,547 )     (383,801 )     (478,748 )     (383,910 )
Interest on cash held in the operating account     —       109       5       485  
Dividends and interest earned on marketable securities and cash held in Trust Account     392,372       1,813,045       3,271,475       5,336,705  
Total other income, net     381,735       1,821,723       3,248,088       5,348,190  
                                 
Net (loss) income   $ (305,323 )   $ 1,109,702     $ 1,193,108     $ 4,245,933  
                                 
Weighted average redeemable Class A Ordinary Shares outstanding – basic and diluted     3,923,923       16,000,000       11,266,886       16,000,000  
                                 
Net (loss) income per redeemable Class A Ordinary Share – basic and diluted   $ (0.03 )   $ 0.05     $ 0.07     $ 0.20  
                                 
Weighted average non-redeemable Class A Ordinary Shares and Class B Ordinary Shares outstanding – basic and diluted     5,621,622       5,621,622       5,621,622       5,621,622  
                                 
Net (loss) income per non-redeemable Class A Ordinary Share and Class B Ordinary Share – basic and diluted   $ (0.03 )   $ 0.05     $ 0.07     $ 0.20  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

MELAR ACQUISITION CORP. I

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026

 

    Class A
Ordinary Shares
    Class B
Ordinary Shares
    Additional
Paid-in
    Accumulated     Total
Shareholders’
 
    Shares     Amount     Shares     Amount     Capital     Deficit     Deficit  
Balance – December 31, 2025     —     $ —       5,621,622     $ 562     $ —     $ (6,986,745 )   $ (6,986,183 )
                                                         
Accretion of Class A Ordinary Shares to redemption amount     —       —       —       —       —       (1,513,878 )     (1,513,878 )
                                                         
Net income     —       —       —       —       —       778,261       778,261  
                                                         
Balance – March 31, 2026     —       —       5,621,622       562       —       (7,722,362 )     (7,721,800 )
                                                         
Conversion of Class B Ordinary Shares to Class A Ordinary Shares     5,621,621       562       (5,621,621 )     (562 )     —       —       —  
                                                         
Accretion of Class A Ordinary Shares to redemption amount     —       —       —       —       (78,478 )     3,451,130       3,372,652  
                                                         
Reversal of allocated value of transaction costs to Public Warrants and Private Placement Warrants     —       —       —       —       —       68,669       68,669  
                                                         
Capital contribution from Everli for Trust extension     —       —       —       —       78,478       —       78,478  
                                                         
Net income     —       —       —       —       —       720,170       720,170  
                                                         
Balance – June 30, 2026     5,621,621       562       1       —       —       (3,482,393 )     (3,481,831 )
                                                         
Accretion of Class A Ordinary Shares to redemption amount     —       —       —       —       (235,436 )     (249,009 )     (484,445 )
                                                         
Reversal of allocated value of transaction costs to Public Warrants and Private Placement Warrants     —       —       —       —       —       2,044       2,044  
                                                         
Capital contribution from Everli for Trust extension     —       —       —       —       235,436       —       235,436  
                                                         
Net loss     —       —       —       —       —       (305,323 )     (305,323 )
                                                         
Balance – September 30, 2026     5,621,621     $ 562       1     $ —     $ —     $ (4,034,681 )   $ (4,034,119 )

 

 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

MELAR ACQUISITION CORP. I

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025

 

    Class A     Class B     Additional           Total  
    Ordinary Shares     Ordinary Shares     Paid-in     Accumulated     Shareholders’  
    Shares     Amount     Shares     Amount     Capital     Deficit     Deficit  
Balance – December 31, 2024     —     $ —       5,621,622     $ 562     $            —     $ (5,527,214 )   $ (5,526,652 )
                                                         
Accretion of Class A Ordinary Shares to redemption amount     —       —       —       —       —       (1,736,734 )     (1,736,734 )
                                                         
Net income     —       —       —       —       —       1,579,993       1,579,993  
                                                         
Balance – March 31, 2025     —       —       5,621,622       562       —       (5,683,955 )     (5,683,393 )
                                                         
Accretion of Class A Ordinary Shares to redemption amount     —       —       —       —       —       (1,786,926 )     (1,786,926 )
                                                         
Net income     —       —       —       —       —       1,556,238       1,556,238  
                                                         
Balance – June 30, 2025     —       —       5,621,622       562       —       (5,914,643 )     (5,914,081 )
                                                         
Accretion of Class A Ordinary Shares to redemption amount     —       —       —       —       —       (1,813,045 )     (1,813,045 )
                                                         
Net income     —       —       —       —       —       1,109,702       1,109,702  
                                                         
Balance – September 30, 2025     —     $ —       5,621,622     $ 562     $ —     $ (6,617,986 )   $ (6,617,424 )

 

 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

MELAR ACQUISITION CORP. I

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

    For the Nine Months Ended
September 30,
 
    2026     2025  
Cash Flows from Operating Activities:            
Net income   $ 1,193,108     $ 4,245,933  
Adjustments to reconcile net income to net cash used in operating activities:                
Dividends and interest earned on marketable securities and cash held in Trust Account     (3,271,475 )     (5,336,705 )
Interest due from Everli     (473,911 )     (394,910 )
Interest expense on Working Capital Loan     18,555       —  
Interest expense on Sponsor Loan     478,748       383,910  
Changes in operating assets and liabilities:                
Prepaid expenses     65,995       105,393  
Accounts payable and accrued expenses     1,602,280       458,794  
Net cash used in operating activities     (386,700 )     (537,585 )
                 
Cash Flows from Investing Activities:                
Cash withdrawn from Trust Account in connection with redemptions     131,489,166       —  
Payment of invoices on behalf of Everli     —       (3,232,490 )
Net cash provided by (used in) investing activities     131,489,166       (3,232,490 )
                 
Cash Flows from Financing Activities:                
Redemption of Class A Ordinary Shares     (131,489,166 )     —  
Proceeds from Working Capital Loan     284,229       —  
Proceeds from Sponsor Loan     71,921       3,178,079  
Net cash (used in) provided by financing activities     (131,133,016 )     3,178,079  
                 
Net Change in Cash     (30,550 )     (591,996 )
Cash – Beginning of period     32,075       878,254  
Cash – End of period   $ 1,525     $ 286,258  
                 
Non-cash investing and financing activities:                
Capital contribution from Everli for Trust extension   $ 313,914     $ —  
Reversal of Class A Ordinary Shares issuance costs upon reduction of Deferred Fee   $ 4,959,718     $ —  
Reversal of transaction costs allocated to Public Warrants and Private Placement Warrants upon reduction of Deferred Fee   $ 70,713     $ —  

 

  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

Melar Acquisition Corp. I (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on March 11, 2024. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”).

 

As of September 30, 2026, the Company had not commenced any operations. All activity for the period from March 11, 2024 (inception) through September 30, 2026 relates to the Company’s formation and the Initial Public Offering (as defined below), and subsequent to the Initial Public Offering, identifying a target company for and consummating a Business Combination, including the Everli Business Combination (as defined and described below). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of dividends and interest income on marketable securities and cash held in the Trust Account (as defined below) and interest income on the First Everli Note (as defined below) (see Note 2).

 

The Company’s sponsor is Melar Acquisition Sponsor I LLC, a Delaware limited liability company (the “Sponsor”).

 

On June 20, 2024, the Company consummated the initial public offering of 16,000,000 units of the Company at $10.00 per unit (the “Units”), which included the partial exercise by the several underwriters (the “Underwriters”) of their over-allotment option (the “Over-Allotment Option”) in the amount of 1,000,000 Units (the “Option Units”), at $10.00 per Unit, generating gross proceeds of $160,000,000 (the “Initial Public Offering”), which is discussed in Note 3. Each Unit consists of one Class A ordinary share, par value $0.0001 per share, of the Company (the “Class A Ordinary Shares” and with respect to the Class A Ordinary Shares included in the Units, the “Public Shares”) and one-half of one redeemable warrant of the Company (the “Public Warrants”).

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 5,000,000 warrants (the “Private Placement Warrants,” and together with the Public Warrants, the “Warrants”) at a price of $1.00 per Private Placement Warrant, in a private placement to (i) the Sponsor and (ii) Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC (“CCM”) and Seaport Global Securities LLC (“Seaport,” together with CCM, the “Representatives”), as representatives of the Underwriters, generating gross proceeds of $5,000,000 (the “Private Placement”), which is described in Note 4. Each whole Warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50 per share.

 

The Company’s management (“Management”) has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less the Deferred Fee (as defined below) and taxes payable, if any).

 

The Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (excluding the amount of the Deferred Fee held and taxes payable on the income earned on the Trust Account, if any) at the time of the signing of an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.

 

Following the closing of the Initial Public Offering, on June 20, 2024, an amount of $160,000,000 ($10.00 per Unit) from both the net proceeds of the Initial Public Offering and a portion of the net proceeds from the Private Placement was placed in a trust account (the “Trust Account”) located in the United States, with Continental Stock Transfer & Trust Company (“Continental”) acting as trustee and was initially held in cash, including in demand deposit accounts at a bank, or invested in U.S. Department of the Treasury (“Treasury”) obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, that invest only in direct Treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended Business Combination. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that the Company holds investments in the Trust Account, the Company may, at any time (based on Management’s ongoing assessment of all factors related to the potential status of the Company under the Investment Company Act), instruct Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.

 

6

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Except with respect to dividends and interest earned on the funds held in the Trust Account that may be released to the Company for taxes payable, if any, the proceeds from the Initial Public Offering and the Private Placement will not be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of the Public Shares if the Company is unable to complete the initial Business Combination by December 20, 2026 (as may be further extended by shareholder approval to amend the Company’s amended and restated memorandum and articles of association (the “Amended and Restated Articles”) to extend the date by which the Company must consummate an initial Business Combination) or by such earlier liquidation date as the Company’s board of directors may approve (the “Combination Period”)), subject to applicable law, or (iii) the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Amended and Restated Articles to modify (x) the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (y) any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the holders of the Public Shares (the “Public Shareholders”).

 

The Company will provide the Public Shareholders with the opportunity to redeem, regardless of whether they abstain, vote for, or against, the Company’s initial Business Combination, all or a portion of their Public Shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable, if any), divided by the number of then outstanding Public Shares, subject to the limitations of applicable law and the Amended and Restated Articles. As of September 30, 2026, the amount of the Trust Account was approximately $11.09 per Public Share.

 

The Public Shares subject to redemption were recorded at a redemption value and classified as temporary equity at the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”).

 

The Company has only the duration of the Combination Period to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter (and subject to lawfully available funds therefor), redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable, if any, and up to $100,000 of interest to pay dissolution expenses), divided by the number of then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, dated June 17, 2024 (as amended, the “Letter Agreement”), pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (as defined in Note 5) and Public Shares in connection with (x) the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination and (y) a shareholder vote to approve an amendment to the Amended and Restated Articles to modify (1) the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (2) any other material provisions relating to shareholders’ rights or pre-initial Business Combination; (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Amended and Restated Articles; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period and to liquidating distributions from assets outside the Trust Account; and (iv) vote any Founder Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the initial Business Combination.

 

7

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the Trust Account assets, less income taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company’s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations, and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, there can be no assurance that the Sponsor will be able to satisfy those obligations.

 

Extension Meeting

 

On June 16, 2026, the Company held an extraordinary general meeting of shareholders in lieu of an annual general meeting of shareholders (the “June 2026 Meeting”). At the June 2026 Meeting, the Company’s shareholders approved, among other things, an amendment to the Amended and Restated Articles to extend the end of the Combination Period on a monthly basis up to six (6) times, from June 20, 2026 through December 20, 2026, or such earlier date as determined by the Company’s board of directors (“Extension Amendment Proposal”).

 

In connection with the votes to approve the Extension Amendment Proposal, the holders of 12,076,077 Public Shares properly exercised their right to redeem such shares for cash at a redemption price of approximately $10.89 per share, for an aggregate redemption amount of approximately $131.5 million (the “Meeting Redemptions”). Following the Meeting Redemptions, there are 3,923,923 Public Shares issued and outstanding.

 

Trust Account Contribution

 

In association with the approval of the Extension Amendment Proposal, the Sponsor or its designee has agreed to contribute to the Trust Account on a monthly basis the lesser of (x) $80,000 or (y) $0.02 for each Public Share that is not redeemed. Based on the 3,923,923 Public Shares that remain outstanding after the Meeting Redemptions, the monthly contribution amount is $78,478. In association with the Extension Amendment Proposal, as of September 30, 2026, the Company’s designee, Everli (as defined below), had deposited an aggregate of $313,914 to extend the Combination Period to October 20, 2026.

 

Everli Business Combination

 

On July 30, 2025, the Company entered into an Agreement and Plan of Merger, as amended on October 2, 2025 and December 8, 2025 (as it may be further amended, supplemented and/or restated from time to time, the “Everli Merger Agreement”) with (i) MAC I Merger Sub Inc., a Nevada corporation and a wholly owned subsidiary of the Company (“Merger Sub”), (ii) Everli Global Inc., a Nevada corporation (together with its successors, “Everli”), (iii) the Sponsor, in the capacity as the representative from and after the effective time of the Merger (as defined below) for the shareholders of the Company (other than the Escrowed Seller (as defined below) and his successors and assigns) in accordance with the terms and conditions of the Everli Merger Agreement, and (iv) Salvatore Palella (the “Escrowed Seller”). Pursuant to the Everli Merger Agreement, subject to the terms and conditions set forth therein, upon the consummation of the transactions contemplated thereby (the “Closing”), (a) the Company shall de-register from the Register of Companies in the Cayman Islands by way of continuation out of the Cayman Islands and into the State of Nevada and domesticate as a Nevada corporation (the “Domestication”) and (b) then Merger Sub will merge with and into Everli (the “Merger” and together with the Domestication and the other transactions contemplated by the Everli Merger Agreement, the “Everli Business Combination”), with Everli continuing as the surviving entity and a wholly owned subsidiary of the Company, with Everli’s equity holders receiving shares of common stock of the Company and with certain stockholders of Everli receiving super-voting stock of the Company in exchange for their existing super-voting stock of Everli. The pre-money equity value of Everli in the Everli Business Combination is $180 million (subject to increase for certain financings consummated by Everli prior to the Closing).

 

On October 22, 2026, the Company held an extraordinary general meeting of its shareholders (the “Business Combination Meeting”) and approved, among other things, the Everli Business Combination. Holders of 3,852,564 Public Shares exercised their rights to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $0.8 million will remain in the Trust Account following the completion of such redemptions.

 

For more information regarding the Everli Business Combination, refer to the Company’s Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 31, 2025, August 5, 2025, October 3, 2025, October 24, 2025, December 8, 2025 and January 29, 2026, the Registration Statement on Form S-4, which includes a proxy statement/prospectus, in connection with the Everli Business Combination, which was declared effective by the SEC on October 2, 2026 (the “Everli Registration Statement”) and the other filings the Company and Everli may make from time to time with the SEC.

 

Working Capital Loan

 

On June 11, 2026, the Company issued a promissory note (the “WCL Note”) in the aggregate principal amount of up to $1,500,000 to the Sponsor for working capital purposes (the “Working Capital Loan”). The Working Capital Loan is interest bearing at 17.5% per annum and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date of liquidation of the Company. If, prior to the Business Combination, the principal balance of the Working Capital Loan has not been paid in full, then, at the Sponsor’s option and subject to certain conditions, up to $1,500,000 of the unpaid principal amount of the Working Capital Loan may be converted into warrants of the Company (the “Conversion Warrant”) to purchase Class A Ordinary Shares at a conversion price of $1.00 per Conversion Warrant. The Conversion Warrants shall be identical to the Warrants issued by the Company in the Private Placement. The Conversion Warrants and their underlying securities are entitled to the registration rights set forth in the Working Capital Loan.

 

8

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The embedded conversion option was analyzed for its accounting implications. As such, management determined the embedded conversion feature was not required to be bifurcated.

 

Founder Shares Conversion

 

On June 11, 2026, the Company issued an aggregate of 5,621,621 Class A Ordinary Shares to the Sponsor upon the conversion (the “Founder Shares Conversion”) of an equal number of Class B Ordinary Shares held by the Sponsor. The Class A Ordinary Shares issued in connection with the Founder Shares Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Founder Shares Conversion, including certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial Business Combination.

 

Liquidity, Capital Resources and Going Concern

 

As of September 30, 2026, the Company had $1,525 in its operating bank account and a working capital deficit of $2,464,550.

 

As of September 30, 2026, the Company had until October 20, 2026 to consummate the initial Business Combination, which may be further extended on a monthly basis up to December 20, 2026 pursuant to the Extension Amendment Proposal. If the Company does not complete a Business Combination within the Combination Period, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Articles. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements-Going Concern,” the Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. The working capital deficit and the expectation of significant future costs raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the accompanying unaudited condensed consolidated financial statements are issued. Additionally, Management has determined that the mandatory liquidation and subsequent dissolution, should the Company be unable to complete a Business Combination by the end of the Combination Period, raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the end of the Combination Period. Management plans to address this uncertainty through the closing of its proposed Business Combination. There is no assurance that the Company’s plans to consummate a Business Combination will be successful within the Combination Period. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on March 9, 2026. The interim results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.

 

Principles of Consolidation

 

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, MAC I Merger Sub Inc. All intercompany transactions have been eliminated.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

9

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that, when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the accompanying unaudited condensed consolidated financial statements with another public company that is neither (i) an emerging growth company nor (ii) an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Making estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed consolidated financial statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,525 and $32,075 in cash and no cash equivalents as of September 30, 2026 and December 31, 2025, respectively.

 

Marketable Securities and Cash Held in Trust Account

 

At September 30, 2026 and December 31, 2025, substantially all of the assets held in the Trust Account were held in money market funds that were invested in Treasury securities. The Company accounts for its marketable securities as trading securities under FASB ASC Topic 320, “Investments—Debt and Equity Securities,” where securities are presented at fair value on the accompanying condensed consolidated balance sheets. Trading securities are presented on the accompanying condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in dividends and interest earned on marketable securities and cash held in Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair values of these investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets.

 

Everli Notes

 

On May 30, 2025, the Company entered into a secured promissory note and pledge agreement (the “First Everli Note”) with Everli and a certain stockholder of Everli (the “Pledging Stockholder”) for a principal amount of up to $300,000. The First Everli Note bears interest at an annual compounded rate of 17.5% and was secured by a continuing security interest in all of Everli’s and its subsidiaries’ property and assets, and a pledge of equity interests by the Pledging Stockholder as collateral. The principal and accrued interest of the First Everli Note was due and payable on the earliest of (i) July 29, 2025, if the Term Sheet (as defined in the First Everli Note) was terminated by the Company in its sole discretion; (ii) five (5) business days after any other termination of the Term Sheet in accordance with the terms thereof; (iii) five (5) business days after the termination of a definitive agreement for a Business Combination transaction involving the Company and Everli; and (iv) five (5) business days after Everli’s receipt of at least an aggregate of $5,000,000 in proceeds under a $10 million senior secured convertible loan as contemplated under the Term Sheet.

 

On August 18, 2025, the First Everli Note was amended and restated to, among other things, amend the principal amount of the First Everli Note to $1,000,000, including an original issue discount (an “OID”) of ten percent (10%). On September 12, 2025, the First Everli Note was amended by the first amendment to increase the principal amount to up to $1,250,000. On September 29, 2025, the First Everli Note was amended by the second amendment to increase the principal amount to up to $3,250,000. On March 30, 2026, the First Everli Note was amended by the third amendment to increase the principal amount to up to $3,611,111. There was no change in the maturity date of the First Everli Note following the third amendment.

 

10

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

On October 21, 2025, Everli entered into a secured promissory note and pledge agreement in the principal amount of up to $7,500,000 issued to Melar Capital Group LLC, an affiliate of the Sponsor (“MCG”), by Everli (the “Second Everli Note,” and together with the First Everli Note, the “Everli Notes”) for the aggregate principal amount of $7,500,000, which includes a $750,000 OID. The Second Everli Note bears interest at 17.5% per annum and is secured by the assets of Everli and its subsidiaries. The principal under the Everli Notes satisfied the $10,000,000 Bridge Financing (as defined in the Everli Merger Agreement) requirement as provided in the Everli Merger Agreement. The principal and accrued interest of the Second Everli Note shall be due and payable on the twelve-month anniversary of the issuance date of the note, or October 21, 2026. MCG has a right to convert any outstanding balance under the Second Everli Note into fully paid and nonassessable shares of the Company’s Class A Common Stock at a rate set forth in the Second Everli Note at any time or times on or after the Everli Business Combination. The Company is a signatory to the Second Everli Note to acknowledge, among other things, the conversion right and the parity of the security interest granted under the First Everli Note and the security interest granted under the Second Everli Note. The Second Everli Note creates no direct financial obligation or an off-balance sheet arrangement for the Company.

 

As of September 30, 2026 and December 31, 2025, Everli had borrowed $3,250,000 (via cash borrowings and the payment of multiple invoices by the Company for Everli), under the First Everli Note, as amended, and had an outstanding balance (including interest) of $4,279,773 and $3,805,862, respectively, on the accompanying condensed consolidated balance sheets.

 

The Company complies with the requirements of FASB ASC Topic 835, “Interest” (“ASC 835”), and reports accrued interest and the amortization of the original issue discounts on the accompanying unaudited condensed consolidated statements of operations as “Interest income due from Everli” and reports the loan amount and unpaid interest as “Due from Everli” on the accompanying condensed consolidated balance sheets. For the three and nine months ended September 30, 2026, the Company recognized $159,707 and $473,911, respectively, in amortized OID and accrued interest on the accompanying unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2025, the Company recognized $392,370 and $394,910, respectively, in amortized OID and accrued interest on the unaudited condensed consolidated statements of operations.

 

Offering Costs

 

The Company complies with the requirements of the FASB ASC Topic 340-10-S99, “Accounting for Offering Costs,” and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC Topic 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate Initial Public Offering proceeds from the Units between Public Shares and Public Warrants, using the relative fair value method by allocating Initial Public Offering proceeds first to assigned value of the Public Warrants and then to the Public Shares. Offering costs allocated to the Public Shares were charged to temporary equity. Offering costs allocated to the Warrants were charged to shareholders’ deficit. After Management’s evaluation, the Warrants were accounted for under equity treatment.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature.

 

Net (Loss) Income per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of ordinary shares, (i) redeemable Class A Ordinary Shares and (ii) non-redeemable Class A Ordinary Shares and Class B Ordinary Shares. Income and losses are shared pro rata between the two classes of Ordinary Shares. This presentation assumes a Business Combination as the most likely outcome. Net (loss) income per Ordinary Share is calculated by dividing the net (loss) income by the weighted average Ordinary Shares outstanding for the respective period.

 

The calculation of diluted net (loss) income per Ordinary Share does not consider the effect of the Warrants issued in connection with the Initial Public Offering, 1,500,000 Conversion Warrants that may be issued upon conversion of the Working Capital Loan or the Private Placement to purchase an aggregate of 5,000,000 Class A Ordinary Shares in the calculation of diluted (loss) income per Ordinary Share, because their exercise is contingent upon future events. Accretion associated with the redeemable Class A Ordinary Shares is excluded from earnings per Ordinary Share as the redemption value approximates fair value. At September 30, 2026 and December 31, 2025, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into Ordinary Shares and then share in the earnings of the Company.

 

11

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per Ordinary Share for each class of Ordinary Shares:

 

    For the Three Months Ended     For the Nine Months Ended  
    September 30, 2026     September 30, 2026  
          Non-Redeemable           Non-Redeemable  
    Redeemable
Class A
    Class A and
Class B
    Redeemable
Class A
    Class A and
Class B
 
Basic and diluted net (loss) income per Ordinary Share:                        
Numerator:                        
Allocation of net (loss) income   $ (125,510 )   $ (179,813 )   $ 795,962     $ 397,146  
Denominator:                                
Weighted average Ordinary Shares outstanding     3,923,923       5,621,622       11,266,886       5,621,622  
Basic and diluted net (loss) income per Ordinary Share   $ (0.03 )   $ (0.03 )   $ 0.07     $ 0.07  

 

    For the Three Months Ended     For the Nine Months Ended  
    September 30, 2025     September 30, 2025  
    Redeemable     Non-Redeemable     Redeemable     Non-Redeemable  
    Class A     Class B     Class A     Class B  
Basic and diluted net income per Ordinary Share:                        
Numerator:                        
Allocation of net income   $ 821,179     $ 288,523     $ 3,141,990     $ 1,103,943  
Denominator:                                
Weighted average Ordinary Shares outstanding     16,000,000       5,621,622       16,000,000       5,621,622  
Basic and diluted net income per Ordinary Share   $ 0.05     $ 0.05     $ 0.20     $ 0.20  

 

Income Taxes

 

The Company accounts for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. Management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2026 and December 31, 2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the accompanying unaudited condensed consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the accompanying condensed consolidated balance sheets as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Over-Allotment Option was deemed to be a freestanding financial instrument indexed on the contingently redeemable Public Shares and was accounted for as a liability pursuant to ASC 480.

 

12

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Warrant Instruments

 

The Company accounts for Warrants as either equity-classified or liability-classified instruments based on an assessment of the Warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the Warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the Warrants meet all of the requirements for equity classification under ASC 815, including whether the Warrants are indexed to the Ordinary Shares and whether the Warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of Warrant issuance and as of each subsequent quarterly period end date while the Warrants are outstanding.

 

For issued or modified Warrants that meet all of the criteria for equity classification, the Warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified Warrants that do not meet all the criteria for equity classification, the Warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Accordingly, as of the date of issuance, the Company evaluated and classified the Warrant instruments under equity treatment at its assigned fair value.

 

Class A Ordinary Shares Subject to Possible Redemption

 

The Public Shares contain a redemption feature that allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the initial Business Combination. In accordance with FASB ASC Topic 480-10-S99, “Distinguishing Liabilities from Equity,” the Company classifies Class A Ordinary Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A Ordinary Shares resulted in charges against additional paid-in capital (to the extent available) and an accumulated deficit. Accordingly, as of September 30, 2026 and December 31, 2025, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the accompanying condensed consolidated balance sheets. As of September 30, 2026 and December 31, 2025, the Class A Ordinary Shares subject to redemption reflected in the accompanying condensed consolidated balance sheets are reconciled in the following table:

 

    Shares     Amount  
Class A Ordinary Shares subject to possible redemption, December 31, 2025     16,000,000     $ 171,405,977  
Plus:                
Accretion of carrying value to redemption value     —       1,513,878  
Class A Ordinary Shares subject to possible redemption, March 31, 2026     16,000,000       172,919,855  
Less:                
Redemptions     (12,076,077 )     (131,489,166 )
Accretion of carrying value to redemption value     —       (3,372,652 )
Plus:                
Reversal of Class A Ordinary Shares issuance costs upon reduction of Deferred Fee     —       4,816,355  
Class A Ordinary Shares subject to possible redemption, June 30, 2026     3,923,923       42,874,392  
Plus:                
Accretion of carrying value to redemption value     —       484,445  
Reversal of Class A Ordinary Shares issuance costs upon reduction of Deferred Fee     —       143,363  
Class A Ordinary Shares subject to possible redemption, September 30, 2026     3,923,923     $ 43,502,200  

 

Recent Accounting Pronouncements

 

In November 2024, the FASB issued Accounting Standards Update (“ASU”) No. 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

 

In December 2025, the FASB issued ASU No. 2025-11, “Interim Reporting (Topic 270): Narrow-Scope Improvements” (“ASU 2025-11”), which clarifies the applicability of the interim reporting guidance, the form and content of interim financial statements, and the interim disclosures required, including a principle to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for public business entities for interim reporting periods within annual reporting periods beginning after December 15, 2027, and for all other entities for interim reporting periods within annual reporting periods beginning after December 15, 2028, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11.

 

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.

 

13

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

NOTE 3. INITIAL PUBLIC OFFERING

 

In the Initial Public Offering, the Company sold 16,000,000 Units, which included the partial exercise of the Over-Allotment Option in the amount of 1,000,000 Option Units, at a price of $10.00 per Unit. Each Unit consists of one Class A Ordinary Share and one-half of one redeemable Public Warrant. Each whole Public Warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. Each Public Warrant will become exercisable 30 days after the completion of the initial Business Combination and will expire five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation (see Note 7).

 

NOTE 4. PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor and the Representatives purchased an aggregate of 5,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, or $5,000,000 in the aggregate, in the Private Placement. Of those 5,000,000 Private Placement Warrants, (i) the Sponsor purchased 3,500,000 Private Placement Warrants and (ii) the Representatives purchased an aggregate of 1,500,000 Private Placement Warrants. Each whole Private Placement Warrant entitles the registered holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment.

 

The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering except that, so long as they are held by the Sponsor, the Representatives, or their permitted transferees, the Private Placement Warrants (i) may not (including the Class A Ordinary Shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (ii) are entitled to registration rights and (iii) with respect to Private Placement Warrants held by the Representatives and/or their designees, are not exercisable more than five years from the commencement of sales in the Initial Public Offering in accordance with Financial Industry Regulatory Authority Rule 5110(g)(8).

 

NOTE 5. RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On March 11, 2024, the Sponsor made a capital contribution of $25,000, or approximately $0.004 per share, to cover certain of the Company’s expenses, for which the Company issued 6,060,811 Class B Ordinary Shares to the Sponsor (such shares, the “Founder Shares”). The Founder Shares included an aggregate of up to 790,541 Class B Ordinary Shares subject to forfeiture to the extent that the Over-Allotment Option was not exercised in full, so that the number of Founder Shares would represent 26.0% of the issued and outstanding Ordinary Shares after the Initial Public Offering. In August 2024, the Underwriters allowed the remainder of the Over-Allotment Option to expire resulting in 439,189 Founder Shares being forfeited by the Sponsor.

 

Pursuant to the Letter Agreement, the Sponsor and the Company’s directors and officers have agreed not to transfer, assign or sell any of their Founder Shares and any Class A Ordinary Shares issued upon conversion thereof until the earlier to occur of (i) one year after the completion of the initial Business Combination or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements as the Sponsor and the Company’s directors and officers with respect to any Founder Shares (the “Lock-up”). Notwithstanding the foregoing, if (x) the closing price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the initial Business Combination or (y) if the Company consummates a transaction after the initial Business Combination that results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released from the Lock-up.

 

IPO Promissory Note — Related Party

 

The Sponsor agreed to loan the Company an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering pursuant to a promissory note (the “IPO Promissory Note”). The loan was non-interest bearing, unsecured and due at the earlier of December 31, 2024 or the closing of the Initial Public Offering. The outstanding balance of $249,389 was repaid at the closing of the Initial Public Offering on June 20, 2024. At September 30, 2026 and December 31, 2025, the Company reported no amounts due to the Sponsor on the accompanying condensed consolidated balance sheets and no further borrowings are permitted under the IPO Promissory Note.

 

Administrative Services Agreement

 

The Company entered into an agreement with MCG to pay an aggregate of $10,000 per month for office space, utilities, and secretarial and administrative support services commencing on June 18, 2024 through the earlier of the Company’s consummation of a Business Combination and its liquidation (the “Administrative Services Agreement”). For the three and nine months ended September 30, 2026 and 2025, the Company incurred $30,000 and $90,000, respectively, in fees for these services. At September 30, 2026 and December 31, 2025, the Company reported $120,000 and $30,000, respectively, in the accompanying condensed consolidated balance sheets in accounts payable.

 

14

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Related Party Loans

 

Working Capital Loan

 

On June 11, 2026, the Company issued the WCL Note in the aggregate principal amount of up to $1,500,000 to the Sponsor. The Working Capital Loan is interest bearing at 17.5% per annum and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date of liquidation of the Company. If, prior to the Business Combination, the principal balance of the Working Capital Loan has not been paid in full, then, at the Sponsor’s option and subject to certain conditions, up to $1,500,000 of the unpaid principal amount of the Working Capital Loan may be converted into Conversion Warrants to purchase Class A Ordinary Shares at a conversion price of $1.00 per Conversion Warrant. The Conversion Warrants shall be identical to the Warrants issued by the Company in the Private Placement that took place simultaneously with the Initial Public Offering. The Conversion Warrants and their underlying securities are entitled to the registration rights set forth in the Working Capital Loan. As of September 30, 2026 and December 31, 2025, the Company had an outstanding principal of $284,229 and $0, respectively, under the Working Capital Loan and, as of September 30, 2026 and December 31, 2025, reported $302,784 and $0, respectively, including accrued interest, on the accompanying condensed consolidated balance sheets as Working Capital Loan - related party.

 

Sponsor Loan

 

On May 30, 2025, the Company issued an unsecured promissory note in the aggregate principal amount of up to $300,000 to the Sponsor, for the Sponsor Loan (as amended, the “Sponsor Note”). The Sponsor Loan is interest bearing at a rate of 17.5% per annum, unsecured and due on the earliest of (i) July 29, 2025, if the Term Sheet is terminated by the Company in its sole discretion; (ii) five (5) business days after any other termination of the Term Sheet in accordance with the terms thereof; (iii) five (5) business days after the termination of a definitive agreement for a Business Combination transaction involving the Company and Everli; and (iv) five (5) business days after Everli’s receipt of at least an aggregate of $5,000,000 in proceeds under a $10 million senior secured convertible loan as contemplated under the Term Sheet.

 

On August 18, 2025, the Sponsor Note was amended and restated to, among other things, amend the principal amount of the Sponsor Note up to $1,000,000, including an OID of ten percent (10%). On September 12, 2025, the Sponsor Note was further amended to increase the principal amount to up to $1,250,000. On September 29, 2025, the Sponsor Note was further amended to increase the principal amount to up to $3,250,000. On March 30, 2026, the Sponsor Note was further amended to increase the principal amount to up to $3,611,111. As of September 30, 2026 and December 31, 2025, the Company had borrowed $3,250,000 and $3,178,079, respectively, under the Sponsor Loan and reported $4,268,680 and $3,718,011, respectively (including accrued interest), on the accompanying condensed consolidated balance sheets.

 

The Company complies with the requirements of ASC 835 and reports accrued interest and the amortization of the original issue discount on the unaudited condensed consolidated statements of operations included elsewhere in this Report as “Interest expense on Sponsor Loan” and reports the loan amount and unpaid interest as “Sponsor Loan” on the accompanying condensed consolidated balance sheets. For the three and nine months ended September 30, 2026, the Company recognized $159,547 and $478,748, respectively, in amortized OID and accrued interest expense on the accompanying unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2025, the Company recognized $383,801 and $383,910, respectively, in amortized OID and accrued interest expense on the unaudited condensed consolidated statements of operations.

 

NOTE 6. COMMITMENTS AND CONTINGENCIES

 

Risks and Uncertainties

 

The Company’s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company’s control. The Company’s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s ability to complete an initial Business Combination.

 

15

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Registration Rights Agreement

 

The holders of the (i) Founder Shares, (ii) Private Placement Warrants and (iii) warrants that may be issued upon conversion of Working Capital Loans (and in each case holders of their underlying securities, as applicable) have registration rights to require the Company to register for resale any of the Company’s securities held by them and any other securities of the Company acquired by them prior to the consummation of the initial Business Combination pursuant to a registration rights agreement, dated June 17, 2024, which the Company entered into with the Sponsor and the other signatories thereto. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. Notwithstanding anything to the contrary, the Representatives may only make a demand on one occasion and only during the five-year period beginning on the effective date of the IPO Registration Statement. In addition, the Representatives may participate in a “piggyback” registration only during the seven-year period beginning on the effective date of the IPO Registration Statement. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 2,250,000 Option Units to cover over-allotments, if any. On June 20, 2024, simultaneously with the closing of the Initial Public Offering, the Underwriters partially exercised the Over-Allotment Option to purchase an additional 1,000,000 Option Units, with 45 days to purchase the remaining 1,250,000 Option Units. On August 4, 2024, the remaining Over-Allotment Option expired worthless.

 

The Underwriters were paid a cash underwriting discount of $0.20 per Unit (excluding any Units sold pursuant to the Over-Allotment Option), or $3,000,000 in the aggregate, which was paid upon the closing of the Initial Public Offering. In addition, the Underwriters are entitled to a deferred fee of $0.40 per Unit other than Option Units, and $0.60 per Option Unit, or $6,600,000 in the aggregate (the “Deferred Fee”). The Deferred Fee is payable to the Underwriters from the amounts held in the Trust Account (excluding accrued interest) solely on amounts remaining in the Trust Account following all properly submitted shareholder redemptions in connection with the consummation of the initial Business Combination, subject to the terms of the Underwriting Agreement. In connection with redemptions by holders of Public Shares in association with the June 2026 Meeting, $131,489,166 was removed from the Trust Account and the related Deferred Fee was reduced by $5,030,431. Of the $5,030,431 reduction, $4,885,024 was recorded during the three months ended June 30, 2026 and $145,407 was recorded during the three months ended September 30, 2026, resulting in a Deferred Fee of $1,569,569, or $0.40 per Public Share remaining after the Meeting Redemptions. The reduction of the Deferred Fee resulted in the reversal of $4,959,718 of issuance costs previously charged against Class A Ordinary Shares subject to possible redemption and $70,713 of transaction costs previously allocated to the Public Warrants and Private Placement Warrants, which was recorded to accumulated deficit. At September 30, 2026 and December 31, 2025, the Company reported $1,569,569 and $6,600,000, respectively, on the accompanying condensed consolidated balance sheets as the Deferred Fee.

 

NOTE 7. SHAREHOLDERS’ DEFICIT

 

On June 11, 2026, the Company issued an aggregate of 5,621,621 Class A Ordinary Shares to the Sponsor upon Founder Shares Conversion of an equal number of Class B Ordinary Shares held by the Sponsor. The Class A Ordinary Shares issued in connection with the Founder Shares Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Founder Shares Conversion, including certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial Business Combination.

 

Preference Shares

 

The Company is authorized to issue a total of 5,000,000 preference shares at par value of $0.0001 each. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

 

Class A Ordinary Shares

 

The Company is authorized to issue a total of 500,000,000 Class A Ordinary Shares at par value of $0.0001 each. As of September 30, 2026 and December 31, 2025, there were 5,621,621 and 0, respectively, Class A Ordinary Shares issued and outstanding, excluding 3,923,923 and 16,000,000 Class A Ordinary Shares subject to possible redemption, respectively.

 

Class B Ordinary Shares

 

The Company is authorized to issue a total of 50,000,000 Class B Ordinary Shares at par value of $0.0001 each. On March 11, 2024, the Company issued 6,060,811 Class B Ordinary Shares to the Sponsor for $25,000, or approximately $0.004 per share. The Founder Shares included an aggregate of up to 790,541 Class B Ordinary Shares subject to forfeiture to the extent that the Over-Allotment Option was not exercised in full, so that the number of Founder Shares would represent 26.0% of the issued and outstanding Ordinary Shares after the Initial Public Offering. In August 2024, the Underwriters allowed the remainder of the Over-Allotment Option to expire resulting in 439,189 Founder Shares being forfeited by the Sponsor. On June 11, 2026, 5,621,621 Class B Ordinary Shares held by the Sponsor were converted into an equal number of Class A Ordinary Shares on a one-for-one basis in the Founder Shares Conversion (see Note 1). As of September 30, 2026 and December 31, 2025, there were 1 and 5,621,622, respectively, Class B Ordinary Shares issued and outstanding.

 

16

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The remaining Founder Share will automatically convert into Class A Ordinary Shares concurrently with or immediately following the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A Ordinary Shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class B Ordinary Shares convert into Class A Ordinary Shares will be adjusted (unless the holders of a majority of the outstanding Class B Ordinary Shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A Ordinary Shares issuable upon conversion of all Class B Ordinary Shares (including the Class A Ordinary Shares issued on the Founder Shares Conversion) will equal, in the aggregate, 26% of the sum of (i) the total number of all Class A Ordinary Shares outstanding upon the completion of the Initial Public Offering (including any Class A Ordinary Shares issued pursuant to the exercises of the Over-Allotment Option and excluding the Class A Ordinary Shares issuable upon exercise of the Private Placement Warrants), plus (ii) all Class A Ordinary Shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any warrants issued to the Sponsor or any of its affiliates or to the Company’s officers or directors upon conversion of Working Capital Loans) minus (iii) any redemptions of Public Shares by Public Shareholders in connection with an initial Business Combination; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

 

Holders of the Ordinary Shares are entitled to one vote for each Ordinary Share held on all matters to be voted on by shareholders. Unless specified in the Amended and Restated Articles or as required by the Companies Act (As Revised) of the Cayman Islands or stock exchange rules, an ordinary resolution under Cayman Islands law and the Amended and Restated Articles, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by the Company’s shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting, and pursuant to the Amended and Restated Articles, such actions include amending the Amended and Restated Articles and approving a statutory merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following the initial Business Combination, the holders of more than 50% of the Ordinary Shares voted for the appointment of directors can elect all of the directors. Prior to the consummation of the initial Business Combination, only holders of the Class B Ordinary Shares (i) have the right to vote on the appointment and removal of directors and (ii) are entitled to vote on continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents or to adopt new constitutional documents, in each case, as a result of approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of Class A Ordinary Shares are not entitled to vote on these matters during such time. These provisions of the Amended and Restated Articles may only be amended if approved by a special resolution passed by the affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company.

 

Warrants

 

At September 30, 2026 and December 31, 2025, there were 13,000,000 Warrants outstanding, including 8,000,000 Public Warrants and 5,000,000 Private Placement Warrants. Each whole Warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment as discussed herein. The Warrants cannot be exercised until 30 days after the completion of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier upon redemption or liquidation.

 

The Company will not be obligated to deliver any Class A Ordinary Shares pursuant to the exercise of a Warrant and will have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the Class A Ordinary Shares issuable upon exercise of the Warrants is then effective and a prospectus relating thereto is current. No Warrant will be exercisable and the Company will not be obligated to issue a Class A Ordinary Share upon exercise of a Warrant unless the Class A Ordinary Share issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant will not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any Warrant. In the event that a registration statement is not effective for the exercised Warrants, the purchaser of a Unit containing such Warrant will have paid the full purchase price for the Unit solely for the Class A Ordinary Share underlying such Unit.

 

17

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Under the terms of the Warrant Agreement, dated June 17, 2024, that the Company entered into with Continental (the “Warrant Agreement”), the Company has agreed that, as soon as practicable, but in no event later than 20 business days, after the closing of its Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the IPO Registration Statement or a new registration statement covering the registration under the Securities Act of the Class A Ordinary Shares issuable upon exercise of the Warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within 60 business days following the initial Business Combination and to maintain a current prospectus relating to the Class A Ordinary Shares issuable upon exercise of the Warrants until the expiration of the Warrants in accordance with the provisions of the Warrant Agreement. If a registration statement covering the Class A Ordinary Shares issuable upon exercise of the Warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A Ordinary Shares are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify the Class A Ordinary Shares under applicable blue sky laws to the extent an exemption is not available.

 

If the holders exercise their Public Warrants on a cashless basis, they would pay the warrant exercise price by surrendering the Public Warrants for that number of Class A Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of Class A Ordinary Shares issuable upon exercise of the Public Warrants, multiplied by the excess of the “fair market value” of the Class A Ordinary Shares over the exercise price of the Public Warrants by (y) the fair market value. The “fair market value” is the average reported closing price of the Class A Ordinary Shares for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of Public Warrants, as applicable.

 

The Company may redeem the outstanding Public Warrants:

 

  ● in whole and not in part;
     
  ● at a price of $0.01 per Public Warrant;
     
  ● upon a minimum of 30 days’ prior written notice of redemption; and
     
  ● if, and only if, the closing price of the Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of Class A Ordinary Shares issuable upon exercise or the exercise price of a Public Warrant) for any 20 trading days within a 30-trading day period commencing at least 30 days after completion of the initial Business Combination and ending three business days before the Company sends the notice of redemption to the warrant holders.

 

Additionally, if the number of outstanding Class A Ordinary Shares is increased by a share capitalization payable in Class A Ordinary Shares, or by a subdivision of Ordinary Shares or other similar event, then, on the effective date of such share capitalization, subdivision or similar event, the number of Class A Ordinary Shares issuable upon exercise of each Warrant will be increased in proportion to such increase in the outstanding Ordinary Shares. A rights offering made to all or substantially all holders of Ordinary Shares entitling holders to purchase Class A Ordinary Shares at a price less than the fair market value will be deemed a share capitalization of a number of Class A Ordinary Shares equal to the product of (i) the number of Class A Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A Ordinary Shares) and (ii) the quotient of (x) the price per Class A Ordinary Share paid in such rights offering and (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for Class A Ordinary Shares, in determining the price payable for Class A Ordinary Shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of Class A Ordinary Shares as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the Class A Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 

18

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

NOTE 8. FAIR VALUE MEASUREMENTS

 

The fair value of the Company’s financial assets and liabilities reflects Management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
  Level 3: Unobservable inputs based on an assessment of the assumptions that market participants would use in pricing the asset or liability.

 

The following table presents information about the Company’s assets that are measured at fair value as of September 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

    Level 1  
    September 30,     December 31,  
    2026     2025  
Assets:            
Marketable securities held in Trust Account   $ 43,501,335     $ 171,404,905  

 

NOTE 9. SEGMENT INFORMATION

 

FASB ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (the “CODM”), or group, in deciding how to allocate resources and assess performance.

 

The Company’s CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, Management has determined that the Company only has one operating segment.

 

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the accompanying unaudited condensed consolidated statements of operations as net income or loss. The measure of segment assets is reported on the accompanying condensed consolidated balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics, which include the following:

  

    September 30,     December 31,  
    2026     2025  
Marketable securities and cash held in Trust Account   $ 43,502,200     $ 171,405,977  
Cash   $ 1,525     $ 32,075  

 

    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
General and administrative costs   $ 687,058     $ 712,021     $ 2,054,980     $ 1,102,257  
Dividends and interest earned on marketable securities and cash held in Trust Account   $ 392,372     $ 1,813,045     $ 3,271,475     $ 5,336,705  

 

19

 

 

MELAR ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The CODM reviews dividends and interest earned on marketable securities and cash held in the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Investment Management Trust Agreement, dated June 17, 2024, which the Company entered into with Continental, as trustee of the Trust Account.

 

General and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Combination Period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative costs, as reported on the accompanying unaudited condensed consolidated statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

 

All other segment items included in net income or loss are reported on the accompanying unaudited condensed consolidated statements of operations and described within their respective disclosures.

 

NOTE 10. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the accompanying condensed consolidated balance sheet date up to the date that the accompanying unaudited condensed consolidated financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the accompanying unaudited condensed consolidated financial statements, other than as discussed below.

 

The Everli Registration Statement was declared effective on October 2, 2026. On October 22, 2026, the Company held the Business Combination Meeting and approved, among other things, the Everli Business Combination. Holders of 3,852,564 Public Shares exercised their rights to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $0.8 million will remain in the Trust Account following the completion of such redemptions.

 

20

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Cautionary Note Regarding Forward-Looking Statements

 

All statements other than statements of historical fact included in this Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 (this “Report”) including, without limitation, statements under this Item regarding our financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in this Report under Item 1. “Financial Statements.”

 

Overview

 

We are a blank check company incorporated in the Cayman Islands on March 11, 2024 for the purpose of effecting a Business Combination. Our Sponsor is Melar Acquisition Sponsor I LLC.

 

We are an early stage and emerging growth company and, as such, we are subject to all of the risks associated with early stage and emerging growth companies. We expect to continue to incur significant costs in the pursuit of our acquisition plans. There can be no assurance that our plans to complete a Business Combination, including the Everli Business Combination, will be successful.

 

Our IPO Registration Statement became effective on June 17, 2024. On June 20, 2024, we consummated our Initial Public Offering of 16,000,000 Units, including 1,000,000 Option Units issued pursuant to the partial exercise of the Over-Allotment Option. Each Unit consists of one Public Share and one-half of one Public Warrant. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to us of $160,000,000.

 

21

 

 

Simultaneously with the closing of the Initial Public Offering and pursuant to the Private Placement Warrants Purchase Agreements, we completed the private sale of an aggregate of 5,000,000 Private Placement Warrants to our Sponsor, CCM and Seaport in the Private Placement at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to our Company of $5,000,000. Of those 5,000,000 Private Placement Warrants, (i) the Sponsor purchased 3,500,000 Private Placement Warrants and (ii) CCM and Seaport purchased an aggregate of 1,500,000 Private Placement Warrants. The Private Placement Warrants are identical to the Public Warrants, except as otherwise disclosed in the IPO Registration Statement.

 

Following the closing of the Initial Public Offering and Private Placement, an amount of $160,000,000 from the net proceeds of the Initial Public Offering and the Private Placement was initially placed in the Trust Account located in the United States with Continental acting as trustee. Pursuant to the Trust Agreement, the Trust Account may be invested only (i) in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act with a maturity of 185 days or less, (ii) in any open-ended investment company that holds itself out as a money market fund selected by us meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, (iii) as uninvested cash or (iv) in interest or non-interest bearing demand deposit accounts at a U.S. chartered commercial bank with consolidated assets of $100 billion or more selected by the Trustee that is reasonably satisfactory to us, until the earlier of: (x) the completion of the Business Combination and (y) the distribution of the Trust Account, as described below.

 

We have until December 20, 2026 (as extended and discussed below), or until such (x) earlier date as our Board may approve or (y) later date as our shareholders may approve, pursuant to the Amended and Restated Articles, to consummate the Business Combination. If we are unable to complete the Business Combination by the end of the Combination Period, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay taxes, if any, divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board, dissolve and liquidate, subject, in each case, to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

We may seek to extend the Combination Period consistent with applicable laws, regulations and stock exchange rules by amending our Amended and Restated Articles. Any such amendment would require the approval of our Public Shareholders, who will be provided the opportunity to redeem all or a portion of their Public Shares in connection with the vote on such approval. Such redemptions will decrease the amount held in our Trust Account and our capitalization, and may affect our ability to maintain our listing on Nasdaq. In addition, the Nasdaq Rules currently require SPACs (such as us) to complete their initial Business Combination in accordance with the Nasdaq 36-Month Requirement. If we do not meet the Nasdaq 36-Month Requirement, our securities will likely be subject to suspension of trading and delisting from Nasdaq. Our Sponsor may also, in its discretion, consider selling its interest in our Company to another sponsor entity, which may result in a change to our Management Team.

 

Shareholders’ Meetings

 

On June 16, 2026, we held an extraordinary general meeting of shareholders in lieu of an annual general meeting of shareholders (the “June 2026 Meeting”). At the June 2026 Meeting, our shareholders approved, among other things, an amendment to our Amended and Restated Articles to extend the end of the Combination Period on a monthly basis up to six (6) times, from June 20, 2026 through December 20, 2026, or such earlier date as determined by the Board (the “Extension Amendment Proposal”).

 

In connection with the votes to approve the Extension Amendment Proposal, the holders of 12,076,077 Public Shares properly exercised their right to redeem such shares for cash at a redemption price of approximately $10.89 per share, for an aggregate redemption amount of approximately $131.5 million (the “Meeting Redemptions”). Following the Meeting Redemptions, there were 3,923,923 Public Shares issued and outstanding.

 

On October 22, 2026, the Company held an extraordinary general meeting of its shareholders (the “Business Combination Meeting”) and approved, among other things, the Everli Business Combination. Holders of 3,852,564 Public Shares exercised their rights to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $0.8 million will remain in the Trust Account following the completion of such redemptions.

 

Trust Account Contribution

 

In association with the approval of the Extension Amendment Proposal, the Sponsor or its designee has agreed to contribute to the Trust Account on a monthly basis the lesser of (x) $80,000 or (y) $0.02 for each Public Share that is not redeemed. Based on the 3,923,923 Public Shares that remain outstanding after the Meeting Redemptions, the monthly contribution amount is $78,478.46. In association with the Extension Amendment Proposal, as of September 30, 2026, the Company’s designee, Everli, had deposited an aggregate of $313,914 to extend the Combination Period to October 20, 2026.

 

22

 

 

Everli Business Combination

 

On July 30, 2025, we entered into the Everli Merger Agreement with (i) the Merger Sub, (ii) Everli, (iii) the Sponsor, as the SPAC Representative, and (iv) the Escrowed Seller. On October 2, 2025, the parties to the Everli Merger Agreement entered into the First Everli Merger Agreement Amendment, pursuant to which, the deadline for Everli to procure at least $10,000,000 in Bridge Financing (as defined in the Everli Merger Agreement), the failure of which entitles Everli to terminate the Everli Merger Agreement, was extended from September 30, 2025 to October 21, 2025. On December 8, 2025, the parties to the Everli Merger Agreement entered into the Second Everli Merger Agreement Amendment, pursuant to which the parties thereto extended the GAAP Audit Delivery Date from November 30, 2025 to January 16, 2026. We have waived the right to receive the GAAP Audited Everli Financials by the GAAP Audit Delivery Date, provided that such deliverables are received by January 31, 2026. Such deliverables were received by January 31, 2026.

 

Pursuant to the Everli Merger Agreement, subject to the terms and conditions set forth therein, (i) prior to the Closing, we will continue out of the Cayman Islands and into the State of Nevada and domesticate as a Nevada corporation, and (ii) at the Closing, Merger Sub will merge with and into Everli, with Everli continuing as the surviving entity and wholly owned subsidiary of our Company, and with each Everli shareholder receiving shares of our Common Stock (as defined in the Everli Merger Agreement) at the Closing, as further described below.

 

The Everli Merger Agreement provides that the total consideration received by the Everli security holders from us at the Closing will be a number of shares of our Common Stock with an aggregate value equal to the sum of (i) One Hundred and Eighty Million Dollars ($180,000,000) plus (ii) the gross proceeds of the Bridge Financing, if any, that has converted into Everli common stock, plus (iii) the Everli Equity Investment (as defined in the Everli Merger Agreement), if any, with each share of our Common Stock valued at $10.00.

 

The Everli Registration Statement was declared effective on October 2, 2026. On October 22, 2026, the Company held the Business Combination Meeting and approved, among other things, the Everli Business Combination. Holders of 3,852,564 Public Shares exercised their rights to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $0.8 million will remain in the Trust Account following the completion of such redemptions.

 

For a full description of the Everli Merger Agreement and the proposed Everli Business Combination, please see Item 1. “Business” of our 2025 Annual Report and the Everli Registration Statement.

 

Working Capital Loan

 

On June 11, 2026, we issued the WCL Note in the aggregate principal amount of up to $1,500,000 to the Sponsor. The Working Capital Loan is interest bearing at 17.5% per annum and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date of liquidation of the Company. If, prior to the Business Combination, the principal balance of the Working Capital Loan has not been paid in full, then, at the Sponsor’s option and subject to certain conditions, up to $1,500,000 of the unpaid principal amount of the Working Capital Loan may be converted into Conversion Warrants to purchase Class A Ordinary Shares at a conversion price of $1.00 per Conversion Warrant. The Conversion Warrants shall be identical to the Warrants issued in the Private Placement that took place simultaneously with the Initial Public Offering. The Conversion Warrants and their underlying securities are entitled to the registration rights set forth in the Working Capital Loan.

 

23

 

 

Founder Shares Conversion

 

On June 11, 2026, we issued an aggregate of 5,621,621 Class A Ordinary Shares to the Sponsor upon the Founder Shares Conversion of an equal number of Class B Ordinary Shares held by the Sponsor. The Class A Ordinary Shares issued in connection with the Founder Shares Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Founder Shares Conversion, including certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial Business Combination.

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities from March 11, 2024 (inception) through September 30, 2026 were organizational activities, those necessary to prepare for the Initial Public Offering, as described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of dividends and interest income on marketable securities and cash held in the Trust Account, located in the United States, with Continental acting as trustee. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

 

For the three months ended September 30, 2026, we had a net loss of $305,323, which consists of general and administrative costs of $687,058, interest expense on the Working Capital Loan of $10,797 and interest expense on the Sponsor Loan of $159,547, partially offset by dividends and interest earned on marketable securities and cash held in the Trust Account of $392,372 and interest due from Everli of $159,707.

 

For the three months ended September 30, 2025, we had net income of $1,109,702, which consists of dividends and interest earned on marketable securities and cash held in the Trust Account of $1,813,045, interest due from Everli of $392,370 and interest on cash held in the operating account of $109, partially offset by general and administrative costs of $712,021 and interest expense on the Sponsor Loan of $383,801.

 

For the nine months ended September 30, 2026, we had net income of $1,193,108, which consists of dividends and interest earned on marketable securities and cash held in the Trust Account of $3,271,475, interest due from Everli of $473,911 and interest on cash held in the operating account of $5, partially offset by general and administrative costs of $2,054,980, interest expense on the Working Capital Loan of $18,555, and interest expense on the Sponsor Loan of $478,748.

 

For the nine months ended September 30, 2025, we had net income of $4,245,933, which consists of dividends and interest earned on marketable securities and cash held in the Trust Account of $5,336,705, interest due from Everli of $394,910 and interest on cash held in the operating account of $485, partially offset by general and administrative costs of $1,102,257 and interest expense on the Sponsor Loan of $383,910.

 

Liquidity, Capital Resources and Going Concern

 

Following the Initial Public Offering, including the partial exercise of the Over-Allotment Option, and the Private Placement, a total of $160,000,000 was placed in the Trust Account.

 

For the nine months ended September 30, 2026, cash used in operating activities was $386,700. Net income of $1,193,108 was adjusted for dividends and interest earned on marketable securities and cash held in the Trust Account of $3,271,475, interest due from Everli of $473,911, interest expense on the Working Capital Loan of $18,555 and interest due on Sponsor Loan of $478,748. Changes in operating assets and liabilities provided $1,668,275 of cash for operating activities.

 

24

 

 

For the nine months ended September 30, 2025, cash used in operating activities was $537,585. Net income of $4,245,933 was affected by dividends and interest earned on marketable securities and cash held in the Trust Account of $5,336,705, interest due from Everli of $394,910 and interest due on Sponsor Loan of $383,910. Changes in operating assets and liabilities provided $564,187 of cash for operating activities.

 

As of September 30, 2026 and December 31, 2025, we had marketable securities held in the Trust Account of $43,502,200 and $171,405,977, respectively. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (which interest shall be net of taxes payable, if any, and exclude the Deferred Fee), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time (based on our Management Team’s ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.

 

As of September 30, 2026 and December 31, 2025, we had cash held outside of the Trust Account of $1,525 and $32,075, respectively. We use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants, or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

 

Our liquidity needs through September 30, 2026 have been satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares, (ii) loans pursuant to the IPO Promissory Note, Working Capital Loan and Sponsor Note, and (iii) the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside the Trust Account.

 

Promissory Notes

 

IPO Promissory Note

 

Prior to the closing of our Initial Public Offering, on March 11, 2024, our Sponsor agreed to loan us an aggregate of up to $300,000 under the IPO Promissory Note to cover expenses related to the Initial Public Offering. Such loans and advances were non-interest bearing and payable on the earlier of December 31, 2024 or the completion of our Initial Public Offering. The loan of $249,389 was fully repaid upon the consummation of our Initial Public Offering on June 20, 2024. No additional borrowing is available under the IPO Promissory Note.

 

Everli Notes

 

On May 30, 2025, we entered into the First Everli Note with Everli and the Pledging Stockholder for a principal amount of up to $300,000. The First Everli Note bore interest at an annual compounded rate of 17.5% and was secured by a continuing security interest in all of Everli’s and its subsidiaries’ property and assets, and a pledge of equity interests by the Pledging Stockholder as collateral. The principal and accrued interest of the First Everli Note was due and payable on the earliest of (i) July 29, 2025, if the Term Sheet (as defined in the First Everli Note) was terminated by our Company in our sole discretion; (ii) five (5) business days after any other termination of the Term Sheet in accordance with the terms thereof; (iii) five (5) business days after the termination of a definitive agreement for a Business Combination transaction involving us and Everli; and (iv) five (5) business days after Everli’s receipt of at least an aggregate of $5,000,000 in proceeds under a $10 million senior secured convertible loan as contemplated under the Term Sheet.

 

25

 

 

On August 18, 2025, the First Everli Note was amended and restated to, among other things, amend the principal amount of the First Everli Note up to $1,000,000, including an OID of ten percent (10%). On September 12, 2025, the First Everli Note was amended by the first amendment to increase the principal amount to up to $1,250,000. On September 29, 2025, the First Everli Note was amended by the second amendment to increase the principal amount to up to $3,250,000. On March 30, 2026, the First Everli Note was amended by the third amendment to increase the principal amount to up to $3,611,111. There was no change in the maturity date of the First Everli Note following the third amendment.

 

On October 21, 2025, Everli entered into the Second Everli Note with MCG, an affiliate of the Sponsor, for the aggregate principal amount of $7,500,000, which includes a $750,000 original issue discount. The Second Everli Note bears interest at 17.5% per annum and is secured by the assets of Everli and its subsidiaries. The principal under the Everli Notes satisfied the $10,000,000 Bridge Financing (as defined in the Everli Merger Agreement) requirement as provided in the Everli Merger Agreement. The principal and accrued interest of the Second Everli Note shall be due and payable on the twelve-month anniversary of the issuance date of the note, or October 21, 2026. MCG has a right to convert any outstanding balance under the Second Everli Note into fully paid and nonassessable shares of our Class A Common Stock at a rate set forth in the Second Everli Note at any time or times on or after the Everli Business Combination. We were a signatory to the Second Everli Note to acknowledge, among other things, the conversion right and the parity of the security interest granted under the First Everli Note and the security interest granted under the Second Everli Note. The Second Everli Note creates no direct financial obligation or an off-balance sheet arrangement for us.

  

As of September 30, 2026 and December 31, 2025, Everli had borrowed $3,250,000 (via cash borrowings and the payment of multiple invoices by us for Everli), under the First Everli Note, as amended, and had an outstanding balance (including interest) of $4,279,773 and $3,805,862, respectively, reflected on the condensed consolidated balance sheets included elsewhere in this Report.

 

We comply with the requirements of FASB ASC Topic 835, “Interest” (“ASC 835”) and report accrued interest and the amortization of the original issue discounts on the unaudited condensed consolidated statements of operations included elsewhere in this Report as “Interest income due from Everli” and report the loan amount and unpaid interest as “Due from Everli” on the condensed consolidated balance sheets included elsewhere in this Report. For the three and nine months ended September 30, 2026, the Company recognized $159,707 and $473,911, respectively, in amortized OID and accrued interest on the unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2025, the Company recognized $392,370 and $394,910, respectively, in amortized OID and accrued interest on the unaudited condensed consolidated statements of operations.

 

Sponsor Note

 

On May 30, 2025, we issued the Sponsor Note in the aggregate principal amount of up to $300,000 to the Sponsor, for the Sponsor Loan. The Sponsor Loan is interest bearing at a rate of 17.5% per annum, unsecured and due on the earliest of (i) July 29, 2025, if the Term Sheet is terminated by us in our sole discretion; (ii) five (5) business days after any other termination of the Term Sheet in accordance with the terms thereof; (iii) five (5) business days after the termination of a definitive agreement for a Business Combination transaction involving us and Everli; and (iv) five (5) business days after Everli’s receipt of at least an aggregate of $5,000,000 in proceeds under a $10 million senior secured convertible loan as contemplated under the Term Sheet.

  

On August 18, 2025, the Sponsor Note was amended and restated to, among other things, amend the principal amount of the Sponsor Note up to $1,000,000, including an original issue discount of ten percent (10%). On September 12, 2025, the Sponsor Note was further amended to increase the principal amount to up to $1,250,000. On September 29, 2025, the Sponsor Note was further amended to increase the principal amount to up to $3,250,000. On March 30, 2026, the Sponsor Note was further amended to increase the principal amount to up to $3,611,111. As of September 30, 2026 and December 31, 2025, we had borrowed $3,250,000 and $3,178,079, respectively, under the Sponsor Loan and reported $4,268,680 and $3,718,011, respectively (including interest), on the condensed consolidated balance sheets included elsewhere in this Report.

 

26

 

 

We comply with the requirements of ASC 835 and report accrued interest and the amortization of the original issue discount on the unaudited condensed consolidated statements of operations included elsewhere in this Report as “Interest expense on Sponsor Loan” and report the loan amount and unpaid interest as “Sponsor Loan” on the condensed consolidated balance sheets included elsewhere in this Report. For the three and nine months ended September 30, 2026, we recognized $159,547 and $478,748, respectively, in amortized OID and accrued interest expense on the unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2025, the Company recognized $383,801 and $383,910, respectively, in amortized OID and accrued interest expense on the unaudited condensed consolidated statements of operations.

 

Intercreditor Agreements

 

On May 8, 2026, Melar Lender entered into the Yorkville Intercreditor Agreement with the YA Lender, Everli, for itself and on behalf of its subsidiaries, Salvatore Palella, and Palella Holdings, LLC, a Delaware limited liability company. The Yorkville Intercreditor Agreement provides that the Melar Lender and the YA Lender share pari passu rights in payment and a first-priority security interest over substantially all of Everli’s assets, with principal payments distributed pro rata based on outstanding amounts (subject to specified exclusions), coordinated notice and lien provisions, and mutual consent to each other’s financing arrangements.

 

On May 27, 2026, Melar Lender entered into the Agile Intercreditor Agreement with the Agile Parties and YA Lender, which was acknowledged by Everli, for itself and on behalf of its subsidiaries, Salvatore Palella, and Palella Holdings. The Agile Intercreditor Agreement governs the respective rights, priorities and obligations of the Agile Parties, the Melar Lender and the YA Lender with respect to all indebtedness, liabilities and obligations of Everli, its subsidiaries, Palella Holdings, Palella, and certain other guarantors and pledgors under the applicable loan documents, owed to the Agile Parties, the Melar Lender and the YA Lender under certain promissory notes issued by Everli to each of the Agile Parties, the Melar Lender and the YA Lender, and the related guarantees and security interests.

 

Pursuant to the Agile Intercreditor Agreement, the Agile Parties have agreed that they are subordinate lenders to each of the Senior Creditors, and that all indebtedness owed by Palella Holdings and Palella to the Agile Parties is and shall be junior and subordinate in right of payment and security to the indebtedness evidenced by the promissory notes issued to the Melar Lender and the promissory notes issued to the YA Lender.

 

Working Capital Loans

 

On June 11, 2026, we issued the WCL Note in the aggregate principal amount of up to $1,500,000 to the Sponsor. The Working Capital Loan is interest bearing at 17.5% per annum and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date of liquidation of the Company. If, prior to the Business Combination, the principal balance of the Working Capital Loan has not been paid in full, then, at the Sponsor’s option and subject to certain conditions, up to $1,500,000 of the unpaid principal amount of the Working Capital Loan may be converted into Conversion Warrants to purchase Class A Ordinary Shares at a conversion price of $1.00 per Conversion Warrant. The Conversion Warrants shall be identical to the Warrants issued in the Private Placement that took place simultaneously with the Initial Public Offering. The Conversion Warrants and their underlying securities are entitled to the registration rights set forth in the Working Capital Loan.

 

27

 

 

Going Concern

 

As of September 30, 2026, we had $1,525 in our operating bank account and a working capital deficit of $2,464,550. As of September 30, 2026, we had until October 20, 2026 to consummate an initial Business Combination, which may be further extended on a monthly basis up to December 20, 2026 pursuant to the Extension Amendment Proposal. If we do not complete a Business Combination within the Combination Period, we will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Articles. In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements-Going Concern,” we have incurred and expect to continue to incur significant costs in pursuit of our acquisition plans. The working capital deficit and the expectation of significant future costs raise substantial doubt about our ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. Additionally, Management has determined that the mandatory liquidation and subsequent dissolution, should we be unable to complete a Business Combination by the end of the Combination Period, raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after the end of the Combination Period. Management plans to address this uncertainty through the closing of its proposed Business Combination. There is no assurance that the Company’s plans to consummate a Business Combination will be successful within the Combination Period. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Contractual Obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than as follows:

 

Administrative Services Agreement

 

Commencing on June 18, 2024, and until the completion of our Business Combination or liquidation, we reimburse MCG, an affiliate of the Sponsor, $10,000 per month for office space, utilities, and secretarial and administrative support pursuant to the Administrative Services Agreement. For the three and nine months ended September 30, 2026, the Company incurred $30,000 and $90,000 in fees for these services, respectively. At September 30, 2026 and December 31, 2025, the Company reported $120,000 and $30,000, respectively, in the accompanying condensed consolidated balance sheets in accounts payable.

 

Underwriting Agreement

 

We granted the Underwriters a 45-day option from the date of the Initial Public Offering to purchase up to an additional 2,250,000 Option Units to cover over-allotments, if any. On June 20, 2024, simultaneously with the Initial Public Offering, the Underwriters partially exercised their Over-Allotment Option and purchased 1,000,000 Option Units, with 45 days to purchase the remaining 1,250,000 Option Units. On August 4, 2024, the remaining Over-Allotment Option expired worthless.

 

The Underwriters were paid a cash underwriting discount of $0.20 per Unit (excluding any Units sold pursuant to the Over-Allotment Option), or $3,000,000 in the aggregate, which was paid upon the closing of the Initial Public Offering. Additionally, the Underwriters are entitled to the Deferred Fee of $0.40 per Unit other than Option Units, and $0.60 per Option Unit, or $6,600,000 in the aggregate. The Deferred Fee is payable to the Underwriters from the amounts held in the Trust Account solely on amounts remaining in the Trust Account following all properly submitted shareholder redemptions in connection with the consummation of the initial Business Combination, subject to the terms of the Underwriting Agreement. In connection with redemptions by holders of Public Shares in association with the June 2026 Meeting, $131,489,166 was removed from the Trust Account and the related Deferred Fee was reduced by $5,030,431. Of the $5,030,431 reduction, $4,885,024 was recorded during the three months ended June 30, 2026 and $145,407 was recorded during the three months ended September 30, 2026, resulting in a Deferred Fee of $1,569,569, or $0.40 per Public Share remaining after the Meeting Redemptions. The reduction of the Deferred Fee resulted in the reversal of $4,959,718 of issuance costs previously charged against Class A Ordinary Shares subject to possible redemption and $70,713 of transaction costs previously allocated to the Public Warrants and Private Placement Warrants, which was recorded to accumulated deficit. At September 30, 2026 and December 31, 2025, the Company reported $1,569,569 and $6,600,000, respectively, on the condensed consolidated balance sheets as the Deferred Fee.

 

Registration Rights Agreement

 

The holders of (i) the Founder Shares, (ii) the Private Placement Warrants and (iii) any private placement-equivalent warrants issued in connection with the Working Capital Loans, if any (and in each case holders of their underlying securities, as applicable) are entitled to registration rights pursuant to the Registration Rights Agreement, requiring us to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A Ordinary Shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. CCM and Seaport may only make a demand on one occasion and only during the five-year period beginning on the effective date of the IPO Registration Statement. In addition, CCM and Seaport may participate in a “piggyback” registration only during the seven-year period beginning on the effective date of the IPO Registration Statement. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

28

 

 

Letter Agreement

 

Our Sponsor, directors and officers have entered into the Letter Agreement with us, pursuant to which, they have waived their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if we fail to complete our initial Business Combination within the Combination Period. However, if they acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if we fail to complete our initial Business Combination within the Combination Period.

 

Additionally, pursuant to the Letter Agreement, our Sponsor, directors and officers will not propose any amendment to our Amended and Restated Articles to modify (i) the substance or timing of our obligation to allow redemption in connection with our initial Business Combination or to redeem 100% of our Public Shares if we do not complete our initial Business Combination within the Combination Period or (ii) any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, unless we provide our Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes, divided by the number of then outstanding Public Shares.

 

Critical Accounting Estimates and Standards

 

The preparation of the unaudited condensed consolidated financial statements and notes thereto included elsewhere in this Report in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities, income and expenses, and the disclosure of contingent assets and liabilities, in our unaudited condensed consolidated financial statements. These accounting estimates require the use of assumptions about matters, some of which are highly uncertain at the time of estimation. Management bases its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments, and we evaluate these estimates on an ongoing basis. To the extent actual experience differs from the assumptions used, our unaudited condensed consolidated financial statements and notes thereto included elsewhere in this Report could be materially affected. As of September 30, 2026, we did not have any critical accounting estimates to be disclosed.

 

Recent Accounting Standards

 

In November 2024, the FASB issued ASU No. 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. We are currently evaluating the impact of adopting ASU 2024-03.

 

In December 2025, the FASB issued ASU No. 2025-11, “Interim Reporting (Topic 270): Narrow-Scope Improvements” (“ASU 2025-11”), which clarifies the applicability of the interim reporting guidance, the form and content of interim financial statements, and the interim disclosures required, including a principle to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for public business entities for interim reporting periods within annual reporting periods beginning after December 15, 2027, and for all other entities for interim reporting periods within annual reporting periods beginning after December 15, 2028, with early adoption permitted. We are currently evaluating the impact of adopting ASU 2025-11.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the unaudited condensed consolidated financial statements and notes thereto included elsewhere in this Report.

 

29

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our Management, including our Certifying Officers, as appropriate, to allow timely decisions regarding required disclosure. Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of September 30, 2026.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes to our internal control over financial reporting during the quarterly period ended September 30, 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

30

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

To the knowledge of our Management, there is no material litigation currently pending or contemplated against us, any of our subsidiaries, any of our officers or directors in their capacity as such or against any of our property.

 

Item 1A. Risk Factors

 

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. For additional risks relating to our operations, see the section titled “Risk Factors” contained in our IPO Registration Statement, 2025 Annual Report, and 2026 First Quarter Form 10-Q. As of the date of this Report, there have been no material changes with respect to those risk factors. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise that may also affect our business or ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

 

For the risks related to Everli and the Everli Business Combination, please see the Everli Registration Statement, which was declared effective by the SEC on October 6, 2026.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Unregistered Sales of Equity Securities

 

None.

 

Use of Proceeds

 

There have been no offerings of registered securities and therefore no planned use of proceeds from such offerings during the quarterly period covered by this Report. For a description of the use of proceeds generated in our Initial Public Offering and the Private Placement, see Part I, Item 2 of this Report. There has been no material change in the planned use of proceeds from our Initial Public Offering and Private Placement as described in the IPO Registration Statement. The specific investments in our Trust Account may change from time to time.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

Trading Arrangements

 

During the quarterly period ended September 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

Additional Information

 

None.

 

31

 

 

Item 6. Exhibits

 

The following exhibits are filed as part of, or incorporated by reference into, this Report.

 

No.   Description of Exhibit
3.1   Amendment to Amended and Restated Memorandum and Articles of Association of the Company (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed by the Company on June 17, 2026)
10.1   Promissory Note of the Company, dated June 11, 2026 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed by the Company on June 11, 2026)
31.1*   Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101)

 

* Filed herewith.
** Furnished herewith.

  

32

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  MELAR ACQUISITION CORP. I
     
Date: November 16, 2026 By: /s/ Gautam Ivatury
  Name:  Gautam Ivatury
  Title: Chief Executive Officer
    (Principal Executive Officer)
     
Date: November 16, 2026 By: /s/ Edward Lifshitz
  Name: Edward Lifshitz
  Title: Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

33

 

Keep reading